Page last updated: 2024-10-17

lactic acid and Brain Neoplasms

lactic acid has been researched along with Brain Neoplasms in 269 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research Excerpts

ExcerptRelevanceReference
" Mannitol and the study drug (furosemide or placebo) were administered, and arterial blood gases with electrolytes (sodium, potassium, and lactic acid) and urine output volume were recorded every 30 minutes for 3 hours."9.17The effect of furosemide on intravascular volume status and electrolytes in patients receiving mannitol: an intraoperative safety analysis. ( Bebawy, JF; Gupta, DK; Hemmer, LB; Koht, A; Ramaiah, VK; Zeeni, C, 2013)
"We performed serial (1)H-MRSI examinations to assess intratumoral metabolite intensities in 16 patients receiving high-dose oral tamoxifen monotherapy for recurrent malignant glioma (WHO grade III or IV) as part of a phase II clinical trial."9.13Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma. ( Arnold, DL; Assina, R; Caramanos, Z; Langleben, A; Leblanc, R; Preul, MC; Sankar, T; Villemure, JG, 2008)
"Recent experimental data showed that the PI3K pathway contributes to resistance to temozolomide (TMZ) in paediatric glioblastoma and that this effect is reversed by combination treatment of TMZ with a PI3K inhibitor."7.85In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells. ( Agliano, A; Al-Saffar, NMS; Balarajah, G; Clarke, PA; Jackson, LE; Jones, C; Leach, MO; Marshall, LV; Pearson, ADJ; Sidhu, J; Workman, P, 2017)
"Lactoferrin (Lf) and folic acid (FA) were crosslinked on poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs) for transporting etoposide across the blood-brain barrier (BBB) and treating human brain malignant glioblastoma."7.81Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles. ( Chen, YC; Kuo, YC, 2015)
"In this study, we developed and characterized a delivery system for the epigenetic demethylating drug, decitabine, to sensitize temozolomide-resistant human glioblastoma multiforme (GBM) cells to alkylating chemotherapy."7.81Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide. ( Cui, Y; Irudayaraj, J; Naz, A; Thompson, DH, 2015)
" Celecoxib (CXB), a selective COX-2 inhibitor, is able to control inflammation and pain, to improve the efficacy of radiotherapy, and to inhibit at high doses the growth of cancer cells."7.80New celecoxib multiparticulate systems to improve glioblastoma treatment. ( Barcia, E; Fernández-Carballido, A; García-García, L; Marcianes, P; Negro, S; Slowing, K; Vera, M, 2014)
"Polysorbate 80 coated temozolomide-loaded PLGA-based superparamagnetic nanoparticles (P80-TMZ/SPIO-NPs) were successfully synthesized and characterized as drug carriers and diagnosis agent for malignant brain glioma."7.78Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma. ( Ling, Y; Wei, K; Zhong, S; Zou, F, 2012)
"Implantable and poly (d,l-lactide-co-glycolide) (PLGA) microparticles were developed to deliver temozolomide (TM) continuously in interstitial chemotherapy for glioma."7.77Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats. ( Liu, JM; Yue, ZJ; Zhang, H; Zhang, YH, 2011)
"Temozolomide (TM) has anti-tumor activity in patients with malignant glioma."7.76Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model. ( Liu, JM; Tang, GS; Wang, Y; Yue, ZJ; Zhang, H; Zhang, YH, 2010)
"In an effort to develop new therapeutic strategies to treat malignant gliomas, we have designed poly (lactic-co-glycolic) acid (PLGA) microparticles that deliver imatinib mesylate, a small molecule tyrosine kinase inhibitor."7.75Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. ( Ariel, G; Benny, O; Black, PM; Carroll, RS; Goren, E; Kim, SK; Machluf, M; Menon, LG; Stewman, C, 2009)
"Transferrin (Tf), an iron-transporting serum glycoprotein, which binds to receptors expressed at the surface of most proliferating cells with particularly high expression on erythroblasts and cancer cells, was chosen as the ligand to develop BCNU-loaded biodegradable poly(D,L-lactic acid) nanoparticles (NPs) containing a ligand, which specifically binds to glioma cells, and their anti-tumor ability was evaluated using a C6 glioma model."7.75Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles. ( Albadany, A; Chang, J; Guo, Y; Kang, C; Li, Y; Pu, P; Sheng, J; Yu, S; Yuan, X; Zhang, Z; Zhong, Y, 2009)
"Silver nanoparticles were entrapped inside the functionalized nanoparticles (Ag-PNP-CTX), to allow detection and quantification of the cellular uptake by confocal microscopy, both in vitro and in vivo."5.43A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma. ( Corradini, I; Franchini, MC; Locatelli, E; Matteoli, M; Monaco, I; Passoni, L; Rasile, M; Rodighiero, S; Tamborini, M, 2016)
" Systemically administered drugs are often poorly bioavailable in the brain, and drug efficacy within the central nervous system can be limited by peripheral toxicity."5.42Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma. ( Berens, ME; Chung, EP; Dhruv, HD; DiPerna, DM; Householder, KT; Sirianni, RW; Wohlleb, GM, 2015)
" Unfortunately, despite its appropriate solubilization in vehicle solvents, its poor bioavailability and limited passage of the blood-brain barrier concur to disappointing results requiring the development of new delivery system forms."5.39Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency. ( Andry, MC; Callewaert, M; Dukic, S; Gafa, V; Molinari, M; Roullin, VG; Van Gulick, L; Vittier, M, 2013)
"Gliotoxins are a group of amino acids that are toxic to astrocytes, and are substrates of high-affinity sodium-dependent glutamate transporters."5.32Gliotoxins disrupt alanine metabolism and glutathione production in C6 glioma cells: a 13C NMR spectroscopic study. ( Brennan, L; Hewage, C; Malthouse, JP; McBean, GJ, 2004)
" Mannitol and the study drug (furosemide or placebo) were administered, and arterial blood gases with electrolytes (sodium, potassium, and lactic acid) and urine output volume were recorded every 30 minutes for 3 hours."5.17The effect of furosemide on intravascular volume status and electrolytes in patients receiving mannitol: an intraoperative safety analysis. ( Bebawy, JF; Gupta, DK; Hemmer, LB; Koht, A; Ramaiah, VK; Zeeni, C, 2013)
"We performed serial (1)H-MRSI examinations to assess intratumoral metabolite intensities in 16 patients receiving high-dose oral tamoxifen monotherapy for recurrent malignant glioma (WHO grade III or IV) as part of a phase II clinical trial."5.13Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma. ( Arnold, DL; Assina, R; Caramanos, Z; Langleben, A; Leblanc, R; Preul, MC; Sankar, T; Villemure, JG, 2008)
" A preclinical technique called deuterium metabolic imaging has successfully imaged the Warburg Effect in vivo in glioblastoma."5.01New metabolic imaging tools in neuro-oncology. ( Corbin, ZA, 2019)
"Lactic acidosis has been reported in solid tumor microenvironment (TME) including glioblastoma (GBM)."4.31Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma. ( Altieri, R; Barbagallo, GMV; Broggi, G; Busi, F; Caltabiano, R; Caruso, M; Di Rosa, M; Forte, S; Giallongo, C; Li Volti, G; Liso, A; Lolicato, M; Longhitano, L; Mione, MC; Parenti, R; Raciti, G; Tibullo, D; Vicario, N, 2023)
"To investigate the effect of lactic acid-induced upregulation of PLEKHA4 expression on biological behaviors of glioma cells and the possible molecular mechanism."4.31[Lactate-induced up-regulation of PLEKHA4 promotes proliferation and apoptosis of human glioma cells]. ( Chen, T; Wang, N; Xi, B; Xu, W; Ye, J, 2023)
"Nanoparticles containing mixed lipid monolayer shell, biodegradable polymer core and rabies virus glycoprotein (RVG) peptide as brain targeting ligand, were developed for brain targeted delivery of paclitaxel (PTX) to treat malignant glioma."3.85Targeted delivery of nano-PTX to the brain tumor-associated macrophages. ( Do, L; Dou, H; Payne, G; Rodriguez, J; Tao, Y; Thomas, T; Zou, L, 2017)
"Recent experimental data showed that the PI3K pathway contributes to resistance to temozolomide (TMZ) in paediatric glioblastoma and that this effect is reversed by combination treatment of TMZ with a PI3K inhibitor."3.85In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells. ( Agliano, A; Al-Saffar, NMS; Balarajah, G; Clarke, PA; Jackson, LE; Jones, C; Leach, MO; Marshall, LV; Pearson, ADJ; Sidhu, J; Workman, P, 2017)
"Lactoferrin (Lf) and folic acid (FA) were crosslinked on poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs) for transporting etoposide across the blood-brain barrier (BBB) and treating human brain malignant glioblastoma."3.81Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles. ( Chen, YC; Kuo, YC, 2015)
"In this study, we developed and characterized a delivery system for the epigenetic demethylating drug, decitabine, to sensitize temozolomide-resistant human glioblastoma multiforme (GBM) cells to alkylating chemotherapy."3.81Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide. ( Cui, Y; Irudayaraj, J; Naz, A; Thompson, DH, 2015)
"Fenofibrate, a well-known normolipidemic drug, has been shown to exert strong anticancer effects against tumors of neuroectodermal origin including glioblastoma."3.81Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier. ( Ayyala, R; Blake, DA; Culicchia, F; Grabacka, M; John, VT; Ponnusamy, T; Reiss, K; Rutkowska, M; Vashistha, H; Waligorski, P; Wilk, A; Wisniewska-Becker, A; Wyczechowska, D; Zapata, A, 2015)
" Celecoxib (CXB), a selective COX-2 inhibitor, is able to control inflammation and pain, to improve the efficacy of radiotherapy, and to inhibit at high doses the growth of cancer cells."3.80New celecoxib multiparticulate systems to improve glioblastoma treatment. ( Barcia, E; Fernández-Carballido, A; García-García, L; Marcianes, P; Negro, S; Slowing, K; Vera, M, 2014)
"Polysorbate 80 coated temozolomide-loaded PLGA-based superparamagnetic nanoparticles (P80-TMZ/SPIO-NPs) were successfully synthesized and characterized as drug carriers and diagnosis agent for malignant brain glioma."3.78Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma. ( Ling, Y; Wei, K; Zhong, S; Zou, F, 2012)
"Implantable and poly (d,l-lactide-co-glycolide) (PLGA) microparticles were developed to deliver temozolomide (TM) continuously in interstitial chemotherapy for glioma."3.77Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats. ( Liu, JM; Yue, ZJ; Zhang, H; Zhang, YH, 2011)
"To demonstrate the feasibility of using DNP hyperpolarized [1-(13)C]-pyruvate to measure early response to temozolomide (TMZ) therapy using an orthotopic human glioblastoma xenograft model."3.77Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging. ( Bok, R; James, CD; Nelson, SJ; Ozawa, T; Park, I; Phillips, JJ; Ronen, SM; Vigneron, DB, 2011)
"Temozolomide (TM) has anti-tumor activity in patients with malignant glioma."3.76Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model. ( Liu, JM; Tang, GS; Wang, Y; Yue, ZJ; Zhang, H; Zhang, YH, 2010)
"Transferrin (Tf), an iron-transporting serum glycoprotein, which binds to receptors expressed at the surface of most proliferating cells with particularly high expression on erythroblasts and cancer cells, was chosen as the ligand to develop BCNU-loaded biodegradable poly(D,L-lactic acid) nanoparticles (NPs) containing a ligand, which specifically binds to glioma cells, and their anti-tumor ability was evaluated using a C6 glioma model."3.75Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles. ( Albadany, A; Chang, J; Guo, Y; Kang, C; Li, Y; Pu, P; Sheng, J; Yu, S; Yuan, X; Zhang, Z; Zhong, Y, 2009)
"In an effort to develop new therapeutic strategies to treat malignant gliomas, we have designed poly (lactic-co-glycolic) acid (PLGA) microparticles that deliver imatinib mesylate, a small molecule tyrosine kinase inhibitor."3.75Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. ( Ariel, G; Benny, O; Black, PM; Carroll, RS; Goren, E; Kim, SK; Machluf, M; Menon, LG; Stewman, C, 2009)
"Direct dialysis could be employed to achieve paclitaxel-loaded PLGA and PLA nanoparticles, which could be internalized by C6 glioma cells and enhance the cytotoxicity of paclitaxel because of its penetration to the cytoplasm and sustained release property."3.73Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel. ( Wang, CH; Xie, J, 2005)
"Gliomas can display marked changes in the concentrations of energy metabolism molecules such as creatine (Cr), phosphocreatine (PCr) and lactate, as measured using magnetic resonance spectroscopy (MRS)."3.71Modeling of pathophysiological coupling between brain electrical activation, energy metabolism and hemodynamics: insights for the interpretation of intracerebral tumor imaging. ( Aubert, A; Benali, H; Costalat, R; Duffau, H, 2002)
" Since lonidamine (LND) is believed to reduce tumor glucose utilization by inhibition of the mitochondrially-bound glycolytic enzyme hexokinase (HK), 31P magnetic resonance spectroscopy (MRS) was used to noninvasively follow the effects of LND on both tumor pH and the high-energy phosphate metabolites: ATP, phosphocreatine (PCr) and inorganic phosphate (Pi) in subcutaneous rat 9L gliosarcomas."3.70Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification. ( Ben-Yoseph, O; Lyons, JC; Ross, BD; Song, CW, 1998)
" Spectroscopy is a reliable technique for grading of gliomas when N-acetyl-aspartate/choline and choline/creatine ratios and presence of lipids are used in combination."3.69Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. ( Chhabra, DK; Gupta, RK; Jain, VK; Pandey, R; Poptani, H; Roy, R, 1995)
"For patients with nonresectable glioblastoma (GB) or recurrent GB, we have recently been using an interstitial chemotherapy with biodegradable polylactic acid pellets containing nimustine chloride (ACNU), in combination with superselective arterial ACNU injection, routine irradiation and chemotherapy."3.69Interstitial chemotherapy with biodegradable ACNU pellet for glioblastoma. ( Akai, F; Ioku, M; Iwasaki, H; Kaetsu, I; Kuroda, R; Nakatani, J; Uchiyama, T, 1994)
"We report the common characteristics of juvenile pilocytic astrocytomas revealed by proton MR spectroscopy."2.40Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. ( Ball, WS; Ballard, E; Dunn, RS; Egnaczyk, GF; Holland, SK; Hwang, JH, 1998)
"Glioblastoma is a malignant brain tumor with poor prognosis."1.91Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma. ( Cheng, Q; Dai, Z; Liang, X; Liu, Z; Luo, P; Wang, Z; Wen, Z; Zhang, H; Zhang, J; Zhang, M; Zhang, X, 2023)
"Glioma is a common type of malignant brain tumour with high mortality and relapse rate."1.56Lactate induced up-regulation of KLHDC8A (Kelch domain-containing 8A) contributes to the proliferation, migration and apoptosis of human glioma cells. ( Chen, T; Lv, K; Yang, H; Zhu, X, 2020)
"High-grade gliomas are associated with poor prognosis."1.56Metabolic response patterns in brain microdialysis fluids and serum during interstitial cisplatin treatment of high-grade glioma. ( Antti, H; Asklund, T; Bergenheim, AT; Bergström, P; Björkblom, B; Johansson, M; Jonsson, P; Tabatabaei, P, 2020)
"Glioblastoma is the most common and malignant brain tumor, and current therapies confer only modest survival benefits."1.51Nuclear Magnetic Resonance Spectroscopy to Identify Metabolite Biomarkers of Nonresponsiveness to Targeted Therapy in Glioblastoma Tumor Stem Cells. ( Berg, HE; Hvinden, IC; Lundanes, E; Rise, F; Sachse, D; Sandberg, CJ; Skaga, E; Skottvoll, FS; Vik-Mo, EO; Wilson, SR, 2019)
"IDH1 mutant gliomas have distinct metabolic and microenvironment characteristics compared with wild type gliomas."1.51Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. ( Chakhoyan, A; Cloughesy, TF; Ellingson, BM; Everson, RG; Lai, A; Liau, LM; Mareninov, S; Nathanson, DA; Nghiemphu, PL; Pope, WB; Prins, RM; Raymond, C; Salamon, N; Yao, J; Yong, WH, 2019)
"We hypothesize that DCA exerts its anticancer effects via depriving cancer of acetate benefits."1.51Dichloroacetate is an antimetabolite that antagonizes acetate and deprives cancer cells from its benefits: A novel evidence-based medical hypothesis. ( Abdel-Aziz, W; Abdel-Latif, HM; Aboonq, MS; Ahmed, NS; Almaramhy, HH; Ayat, M; Baghdadi, H; El Sayed, SM; El-Sawy, SA; Elshazley, M; Ibrahim, W; Mahmoud, AA, 2019)
"Fifty-five patients diagnosed with neuroepithelial tumors of Grades I (3 cases), II (11 cases), III (15 cases), and IV (26 cases) were enrolled."1.48The Significance of Lactate and Lipid Peaks for Predicting Primary Neuroepithelial Tumor Grade with Proton MR Spectroscopy. ( Doi, M; Hoshikawa, M; Nakajima, Y; Nakamura, H; Suzuki, T; Takagi, M; Tanaka, Y; Uchida, M; Yoshida, Y, 2018)
"Glioblastoma multiforme is the most lethal type of brain tumor and the established therapy only extends patients survival to approximately one year."1.48Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment. ( Coelho, MAN; Gosselet, F; Lima, J; Loureiro, JA; Pereira, MC; Ramalho, MJ; Sevin, E, 2018)
"Glioma is one of the most common types of brain tumors."1.46Assessment of alterations in X-ray irradiation-induced DNA damage of glioma cells by using proton nuclear magnetic resonance spectroscopy. ( Li, F; Li, H; Shi, W; Xu, Y; Yi, C; Zeng, Q, 2017)
"Silver nanoparticles were entrapped inside the functionalized nanoparticles (Ag-PNP-CTX), to allow detection and quantification of the cellular uptake by confocal microscopy, both in vitro and in vivo."1.43A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma. ( Corradini, I; Franchini, MC; Locatelli, E; Matteoli, M; Monaco, I; Passoni, L; Rasile, M; Rodighiero, S; Tamborini, M, 2016)
"Metabolic imaging of brain tumors using (13)C Magnetic Resonance Spectroscopy (MRS) of hyperpolarized [1-(13)C] pyruvate is a promising neuroimaging strategy which, after a decade of preclinical success in glioblastoma (GBM) models, is now entering clinical trials in multiple centers."1.43Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring. ( Blough, MD; Cairncross, JG; Chaumeil, MM; Chesnelong, C; Eriksson, P; Luchman, HA; Najac, C; Radoul, M; Ronen, SM; Viswanath, P, 2016)
"It is very challenging to treat brain cancer because of the blood-brain barrier (BBB) restricting therapeutic drug or gene to access the brain."1.42Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles. ( Hao, Y; Li, D; Li, H; Meng, D; Shi, J; Wang, L; Zhang, H; Zhang, Y; Zhang, Z; Zhao, Y, 2015)
" Systemically administered drugs are often poorly bioavailable in the brain, and drug efficacy within the central nervous system can be limited by peripheral toxicity."1.42Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma. ( Berens, ME; Chung, EP; Dhruv, HD; DiPerna, DM; Householder, KT; Sirianni, RW; Wohlleb, GM, 2015)
"Chaetocin-treated tumors exhibited heightened ROS, pATM, YAP1 and pJNK levels."1.40Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism. ( Anto, NP; Dixit, D; Ghildiyal, R; Sen, E, 2014)
"T98G human brain cancer cells were cultivated and cell culture metabolism was measured on-chip."1.40Cell culture monitoring for drug screening and cancer research: a transparent, microfluidic, multi-sensor microsystem. ( Ehret, R; Jobst, G; Kieninger, J; Moser, I; Slotwinski, K; Urban, GA; Wego, M; Weltin, A, 2014)
" Unfortunately, despite its appropriate solubilization in vehicle solvents, its poor bioavailability and limited passage of the blood-brain barrier concur to disappointing results requiring the development of new delivery system forms."1.39Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency. ( Andry, MC; Callewaert, M; Dukic, S; Gafa, V; Molinari, M; Roullin, VG; Van Gulick, L; Vittier, M, 2013)
"Gliomas are resistant to radiation therapy, as well as to TNFα induced killing."1.39ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα. ( Ghildiyal, R; Mehta, VS; Sen, E; Sinha, S, 2013)
"The detection of a small number of circulating tumor cells (CTCs) is important, especially in the early stages of cancer."1.38Nanotextured substrates with immobilized aptamers for cancer cell isolation and cytology. ( Allen, PB; Bachoo, R; Ellington, AD; Iqbal, SM; Kim, YT; Li, N; Mahmood, MA; Wan, Y, 2012)
"In the renal cell carcinoma, in contrast with GBM, (13) C multiplets of γ-aminobutyric acid (GABA) differed from its precursor glutamate, suggesting that GABA did not derive from a common glutamate precursor pool."1.38Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors. ( Bachoo, RM; Cho, SK; Choi, C; Deberardinis, RJ; Good, LB; Hatanpaa, KJ; Jindal, A; Kapur, P; Maher, EA; Malloy, CR; Marin-Valencia, I; Mashimo, T; Mickey, B; Pascual, JM; Raisanen, J; Rakheja, D; Sun, X; Takahashi, M; Togao, O; Vemireddy, V, 2012)
"Celecoxib was incorporated into poly DL-lactide-co-glycolide (PLGA) nanoparticles for antitumor drug delivery."1.37Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells. ( Jeong, YI; Jin, SG; Jung, S; Jung, TY; Kang, SS; Kim, IY; Kim, TH; Moon, KS; Pei, J, 2011)
"Monofocal acute inflammatory demyelination (MAID), which is observable by CT and MRI as a well-enhanced mass lesion with prominent perifocal edema, is very similar to malignant gliomas radiologically, making differential diagnosis of the two pathologies difficult."1.37Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET. ( Aki, T; Asano, Y; Ito, T; Iwama, T; Miwa, K; Shinoda, J; Takenaka, S; Yokoyama, K, 2011)
"Examining the cyst content of brain tumors may contribute in determining the malignancy of the given tumor accompanied by a cyst."1.36Magnetic resonance spectroscopic imaging associated with analysis of fluid in cystic brain tumors. ( Atçi, B; Demircan, N; Ertürk, AR; Ozener, V; Selçuki, M; Turan, Y; Yurt, A, 2010)
"Gliosarcoma is an uncommon variant of glioblastoma multiforme, which is composed of gliomatous and sarcomatous elements."1.35Giant infantile gliosarcoma: magnetic resonance imaging findings. ( Bulakbasi, N; Chen, L; Kocaoglu, M; Onguru, O; Sanal, HT, 2008)
"Paclitaxel was released from the nanoparticles in a biphasic profile with a fast release rate in the first 3 days followed by a slow first-order release."1.34Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. ( Dong, Y; Feng, SS, 2007)
"Using discriminant analysis, this study found that MR spectroscopy in combination with ADC ratio, rather than ADC value, can improve the ability to differentiate recurrent glioma and radiation injury."1.34Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. ( Feng, DC; Li, CF; Liu, H; Zeng, QS; Zhen, JH, 2007)
"Gliomas are heterogeneous tumors with increased microvasculature, hypoxia, and necrosis."1.33Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. ( Cha, S; Chang, SM; Crawford, F; Graves, EE; Li, X; Nelson, SJ; Vigneron, DB, 2005)
"One hundred and four metastatic brain tumors were evaluated by long-echo (TR, 2000 ms; TE, 136 ms) single-voxel volume-selected proton MRS."1.33Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile. ( Chernov, MF; Hayashi, M; Hori, T; Izawa, M; Ono, Y, 2006)
"Gliotoxins are a group of amino acids that are toxic to astrocytes, and are substrates of high-affinity sodium-dependent glutamate transporters."1.32Gliotoxins disrupt alanine metabolism and glutathione production in C6 glioma cells: a 13C NMR spectroscopic study. ( Brennan, L; Hewage, C; Malthouse, JP; McBean, GJ, 2004)
"Combined treatment of primary brain tumors (surgery + postoperative radiotherapy) causes alteration of brain metabolism, even in regions of the brain far from the postoperative tumor bed and receiving relatively low total doses of radiation."1.321H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. ( Maciejewski, B; Rutkowski, T; Sokol, M; Tarnawski, R, 2003)
"Eighty-five brain metastases in 81 patients were investigated before treatment and 16-18h thereafter."1.32Early metabolic changes in metastatic brain tumors after Gamma Knife radiosurgery: 1H-MRS study. ( Abe, K; Chernov, MF; Hayashi, M; Hori, T; Izawa, M; Kubo, O; Ono, Y; Usukura, M, 2004)
"The diagnosis and therapy of childhood brain tumors, most of which are low grade, can be complicated because of their frequent adjacent location to crucial structures, which limits diagnostic biopsy."1.32Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. ( Anthony, DC; Astrakas, LG; Black, PM; De Girolami, U; Tarbell, NJ; Tzika, AA; Zarifi, MK; Zurakowski, D, 2004)
"The differential diagnosis between brain abscesses and necrotic tumors such as glioblastomas is sometimes difficult to establish by conventional computed tomography and magnetic resonance imaging."1.31Brain abscess and glioblastoma identified by combined proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging--two case reports. ( Harada, M; Kageji, T; Nagahiro, S; Nakaiso, M; Takimoto, O; Uno, M, 2002)
"Most of the brain tumors were characterized by strongly reduced total N-acetylaspartyl compounds and marked increases of myo-inositol and choline-containing compounds, consistent with a lack of neuroaxonal tissue and a proliferation of glial cells."1.31Quantitative proton magnetic resonance spectroscopy of focal brain lesions. ( Dechent, P; Frahm, J; Hanefeld, F; Herms, J; Markakis, E; Maxton, C; Wilken, B, 2000)
"The diagnosis of brain tumors after high-dose radiation therapy is frequently limited by the lack of metabolic discrimination available with conventional imaging methods."1.31Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. ( Chang, S; Dillon, WP; Graves, EE; Larson, D; McDermott, M; Nelson, SJ; Prados, MD; Verhey, L; Vigneron, DB, 2001)
"High-grade brain tumors are known to have a high rate of glucose (Glc) consumption."1.31High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. ( Décorps, M; Rémy, C; von Kienlin , M; Ziegler, A, 2001)
"Three epidermoid cysts showed only lactate signal."1.30In vivo single-voxel proton MR spectroscopy in intracranial cystic masses. ( Chang, KH; Han, MC; Han, MH; Jung, HW; Kim, HD; Kim, SH; Seong, SO; Song, IC, 1998)
"Children who have brain tumors are at risk for a variety of treatment-related sequelae, including neuropsychological and cognitive impairment, neurologic deficits, and neuroendocrinologic disturbances."1.30Treatment of brain tumors in children is associated with abnormal MR spectroscopic ratios in brain tissue remote from the tumor site. ( Davis, PC; Morris, R; Padgett, CA; Shapiro, MB; Waldrop, SM, 1998)
"Choline signals were increased in tumour margins of high grade gliomas and more diffusely in low grade gliomas."1.29Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy. ( Go, KG; Heesters, MA; Kamman, RL; Mooyaart, EL, 1993)
"Higher grades of brain tumors in this study were associated with higher Cho/reference and lower NAA/reference values."1.29Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. ( Arai, N; Fujiwara, S; Hara, K; Kayama, T; Kumabe, T; Ono, Y; Sato, K; Shimizu, H; Tominaga, T; Yoshimoto, T, 1996)
"Thirteen cases of brain cancer treated by radiation therapy were examined by 1H magnetic resonance spectroscopy and gadolinium-enhanced T1-weighted magnetic resonance imaging and reexamined at 2-month intervals."1.29Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. ( Levendag, PC; Oudkerk, M; Sijens, PE; van Dijk, P; Vecht, CJ, 1995)
"Choline values were lower in chronic radiation necrosis than in solid anaplastic tumors (P < ."1.28Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. ( Alger, JR; Bizzi, A; Di Chiro, G; Dietz, MJ; Dwyer, AJ; Frank, JA; Fulham, MJ; Raman, R; Shih, HH; Sobering, GS, 1992)
"Experimental brain tumors were produced in rats by stereotactical implantation of various neoplastic cell lines (RG 2, RG1 2."1.27Regional metabolism of experimental brain tumors. ( Dolan, E; Hossmann, KA; Mies, G; Paschen, W; Szabo, L; Wechsler, W, 1986)

Research

Studies (269)

TimeframeStudies, this research(%)All Research%
pre-19905 (1.86)18.7374
1990's41 (15.24)18.2507
2000's77 (28.62)29.6817
2010's119 (44.24)24.3611
2020's27 (10.04)2.80

Authors

AuthorsStudies
Su, X1
Yang, Y1
Yang, Q1
Pang, B1
Sun, S1
Wang, Y2
Qiao, Q1
Guo, C1
Liu, H5
Pang, Q1
Obukhova, LМ1
Nikiforova, ОN1
Kopytova, ТV1
Orlinskaya, NY1
Kontorshchikov, ММ1
Kontorshchikova, KN1
Medyanik, IА1
Grishin, АS1
Vasina, DD1
Udawant, S1
Litif, C1
Lopez, A1
Gunn, B1
Schuenzel, E1
Keniry, M1
Longhitano, L1
Vicario, N1
Forte, S1
Giallongo, C1
Broggi, G1
Caltabiano, R1
Barbagallo, GMV1
Altieri, R1
Raciti, G1
Di Rosa, M1
Caruso, M1
Parenti, R1
Liso, A1
Busi, F1
Lolicato, M1
Mione, MC1
Li Volti, G1
Tibullo, D1
Vassilieva, A1
Møller, K1
Skjøth-Rasmussen, J1
Sørensen, MK1
Guyon, J1
Fernandez-Moncada, I1
Larrieu, CM1
Bouchez, CL1
Pagano Zottola, AC1
Galvis, J1
Chouleur, T1
Burban, A1
Joseph, K1
Ravi, VM1
Espedal, H2
Røsland, GV1
Daher, B1
Barre, A1
Dartigues, B1
Karkar, S1
Rudewicz, J1
Romero-Garmendia, I1
Klink, B1
Grützmann, K1
Derieppe, MA1
Molinié, T1
Obad, N2
Léon, C1
Seano, G1
Miletic, H2
Heiland, DH1
Marsicano, G1
Nikolski, M1
Bjerkvig, R2
Bikfalvi, A2
Daubon, T1
Bazi Alahri, M1
Jibril Ibrahim, A1
Barani, M1
Arkaban, H1
Shadman, SM1
Salarpour, S1
Zarrintaj, P1
Jaberi, J1
Turki Jalil, A1
Wang, Z1
Dai, Z1
Zhang, H5
Liang, X1
Zhang, X2
Wen, Z1
Luo, P1
Zhang, J3
Liu, Z2
Zhang, M2
Cheng, Q1
Capasso, R1
Negro, A1
Russo, C1
Zeccolini, F1
Muto, G1
Caranci, F1
Pinto, A1
Ye, J1
Xu, W1
Xi, B1
Wang, N1
Chen, T2
Ma, S1
Lee, H1
Jo, WY1
Byun, YH1
Shin, KW1
Choi, S1
Oh, H1
Park, CK1
Park, HP1
Maldonado, F1
Fábregas, N1
Aldecoa, I1
González, J1
García-Orellana, M1
Belda, I1
Hurtado, P1
Gracia, I1
de Riva, N1
Tercero, J1
Carrero, E1
Valero, R1
Corbin, ZA1
Branco, M1
Linhares, P1
Carvalho, B1
Santos, P1
Costa, BM1
Vaz, R1
Ni, W1
Xia, Y2
Luo, L1
Wen, F1
Hu, D1
Bi, Y1
Qi, J1
Björkblom, B1
Jonsson, P1
Tabatabaei, P1
Bergström, P1
Johansson, M1
Asklund, T1
Bergenheim, AT2
Antti, H1
Qu, C1
Yan, C1
Cao, W1
Li, F3
Qu, Y1
Guan, K1
Si, C1
Yu, Z1
Qu, Z1
Datta, K1
Lauritzen, MH1
Merchant, M2
Jang, T2
Liu, SC2
Hurd, R1
Recht, L1
Spielman, DM2
Azzalin, A1
Brambilla, F1
Arbustini, E1
Basello, K1
Speciani, A1
Mauri, P1
Bezzi, P1
Magrassi, L1
Xue, W1
Xu, K1
Yi, L1
Guo, Y2
Xie, T1
Tong, H1
Zhou, B1
Wang, S2
Li, Q1
Chen, X2
Fang, J1
Zhang, W1
Bisdas, S1
Schäfer, R1
Kolb, R1
Bender, B1
Klose, U1
Palma, A1
Grande, S1
Ricci-Vitiani, L1
Luciani, AM1
Buccarelli, M1
Biffoni, M1
Dini, V1
Cirrone, GAP1
Ciocca, M1
Guidoni, L1
Pallini, R1
Viti, V1
Rosi, A1
Zhu, X1
Yang, H1
Lv, K1
Kubelt, C1
Peters, S1
Ahmeti, H1
Huhndorf, M1
Huber, L1
Cohrs, G1
Hövener, JB1
Jansen, O1
Synowitz, M1
Held-Feindt, J1
Viswanath, P2
Batsios, G1
Mukherjee, J1
Gillespie, AM1
Larson, PEZ4
Luchman, HA2
Phillips, JJ2
Costello, JF1
Pieper, RO1
Ronen, SM4
Perrillat-Mercerot, A2
Miranville, A2
Agosti, A1
Rocca, E1
Ciarletta, P1
Guillevin, R4
Mishkovsky, M1
Gusyatiner, O1
Lanz, B1
Cudalbu, C1
Vassallo, I1
Hamou, MF1
Bloch, J1
Comment, A1
Gruetter, R2
Hegi, ME1
Reuss, AM1
Groos, D1
Buchfelder, M1
Savaskan, N1
Inoue, A1
Nishikawa, M1
Ohnishi, T1
Yano, H1
Kanemura, Y1
Ohtsuka, Y1
Ozaki, S1
Nakamura, Y1
Matsumoto, S2
Suehiro, S1
Yamashita, D1
Shigekawa, S1
Watanabe, H1
Kitazawa, R1
Tanaka, J1
Kunieda, T1
Huang, WC1
Lu, IL1
Chiang, WH1
Lin, YW1
Tsai, YC1
Chen, HH1
Chang, CW1
Chiang, CS1
Chiu, HC1
Cata, JP1
Bhavsar, S1
Hagan, KB1
Arunkumar, R1
Grasu, R1
Dang, A1
Carlson, R1
Arnold, B1
Popat, K1
Rao, G1
Potylchansky, Y1
Lipski, I1
Ratty, S1
Nguyen, AT1
McHugh, T1
Feng, L1
Rahlfs, TF1
Son, MJ1
Ryu, JS1
Kim, JY1
Kwon, Y1
Chung, KS1
Mun, SJ1
Cho, YS1
Al-Saffar, NMS1
Agliano, A1
Marshall, LV1
Jackson, LE1
Balarajah, G1
Sidhu, J1
Clarke, PA3
Jones, C1
Workman, P1
Pearson, ADJ1
Leach, MO4
Miranda-Gonçalves, V2
Bezerra, F1
Costa-Almeida, R1
Freitas-Cunha, M1
Soares, R1
Martinho, O1
Reis, RM2
Pinheiro, C1
Baltazar, F2
Nakamura, H1
Doi, M1
Suzuki, T1
Yoshida, Y1
Hoshikawa, M1
Uchida, M1
Tanaka, Y1
Takagi, M1
Nakajima, Y1
Yenugonda, V1
Nomura, N1
Kouznetsova, V1
Tsigelny, I1
Fogal, V1
Nurmemmedov, E1
Kesari, S1
Babic, I1
Eriksson, JA1
Wanka, C1
Burger, MC1
Urban, H1
Hartel, I1
von Renesse, J1
Harter, PN2
Mittelbronn, M2
Steinbach, JP1
Rieger, J1
Crémillieux, Y1
Salvati, R1
Dumont, U1
Pinaud, N1
Bouchaud, V1
Sanchez, S1
Glöggler, S1
Wong, A1
Ramalho, MJ1
Sevin, E1
Gosselet, F1
Lima, J1
Coelho, MAN1
Loureiro, JA1
Pereira, MC1
Benedicenti, L1
Gianotti, G1
Galban, EM1
Li, H4
Cui, Y3
Shi, W2
Gao, W1
Wang, X2
Zeng, Q2
Kriel, J1
Müller-Nedebock, K1
Maarman, G1
Mbizana, S1
Ojuka, E1
Klumperman, B1
Loos, B1
Lenting, K1
Khurshed, M1
Peeters, TH1
van den Heuvel, CNAM1
van Lith, SAM1
de Bitter, T1
Hendriks, W1
Span, PN1
Molenaar, RJ1
Botman, D1
Verrijp, K1
Heerschap, A3
Ter Laan, M1
Kusters, B1
van Ewijk, A1
Huynen, MA1
van Noorden, CJF1
Leenders, WPJ1
Zhao, M1
Danhier, F1
Bastiancich, C1
Joudiou, N1
Ganipineni, LP1
Tsakiris, N1
Gallez, B1
Rieux, AD1
Jankovski, A1
Bianco, J1
Préat, V1
Righi, V1
García-Martín, ML2
Mucci, A1
Schenetti, L1
Tugnoli, V1
Lopez-Larrubia, P2
Cerdán, S3
Gordon, JW1
Chen, HY2
Autry, A2
Park, I4
Van Criekinge, M2
Mammoli, D2
Milshteyn, E1
Bok, R4
Xu, D2
Li, Y4
Aggarwal, R1
Chang, S3
Slater, JB2
Ferrone, M1
Nelson, S1
Kurhanewicz, J3
Vigneron, DB10
Guillevin, C1
Carlin, D1
Babourina-Brooks, B1
Arvanitis, TN1
Wilson, M1
Peet, AC1
Lei, C1
Davoodi, P1
Zhan, W1
Chow, PK2
Wang, CH6
El Sayed, SM1
Baghdadi, H1
Ahmed, NS1
Almaramhy, HH1
Mahmoud, AA1
El-Sawy, SA1
Ayat, M1
Elshazley, M1
Abdel-Aziz, W1
Abdel-Latif, HM1
Ibrahim, W1
Aboonq, MS1
Shah, SR1
Kim, J1
Schiapparelli, P1
Vazquez-Ramos, CA1
Martinez-Gutierrez, JC1
Ruiz-Valls, A1
Inman, K1
Shamul, JG1
Green, JJ1
Quinones-Hinojosa, A1
Hvinden, IC1
Berg, HE1
Sachse, D1
Skaga, E1
Skottvoll, FS1
Lundanes, E1
Sandberg, CJ1
Vik-Mo, EO1
Rise, F1
Wilson, SR1
Yao, J1
Chakhoyan, A1
Nathanson, DA1
Yong, WH1
Salamon, N1
Raymond, C1
Mareninov, S1
Lai, A1
Nghiemphu, PL1
Prins, RM1
Pope, WB1
Everson, RG1
Liau, LM1
Cloughesy, TF1
Ellingson, BM1
Gordon, J1
Chung, B1
Shin, P1
Carvajal, L1
Crane, J1
Tosi, G1
Bortot, B1
Ruozi, B1
Dolcetta, D1
Vandelli, MA1
Forni, F1
Severini, GM1
Sinha, S1
Ghildiyal, R2
Mehta, VS1
Sen, E2
Garavaglia, M1
Mak, T1
Cusimano, MD1
Rigamonti, A1
Crescini, C1
McCredy, V1
Romaschin, A1
Baker, AJ1
Hare, GM1
Jiang, YS1
Wang, FR1
Lai, JH1
Jan, HJ1
Liu, LW1
Lee, CC1
Wang, SG1
Hueng, DY1
Cheng, YY1
Lee, HM1
Ma, HI1
Bruggers, CS1
Moore, K1
Rahman, CV2
Smith, SJ2
Morgan, PS1
Langmack, KA1
Ritchie, AA2
Macarthur, DC1
Rose, FR1
Shakesheff, KM2
Grundy, RG2
Weltin, A1
Slotwinski, K1
Kieninger, J1
Moser, I1
Jobst, G1
Wego, M1
Ehret, R1
Urban, GA1
Kang, T1
Gao, X1
Hu, Q1
Jiang, D1
Feng, X1
Song, Q1
Yao, L1
Huang, M1
Jiang, X1
Pang, Z1
Chen, H1
Chen, J1
Geldenhuys, W1
Wehrung, D1
Groshev, A1
Hirani, A1
Sutariya, V1
Dixit, D1
Anto, NP1
Kutlu, C1
Çakmak, AS1
Gümüşderelioğlu, M1
Madan, A1
Ganji, SK1
An, Z1
Choe, KS1
Pinho, MC1
Bachoo, RM3
Maher, EM1
Choi, C2
Vera, M1
Barcia, E1
Negro, S1
Marcianes, P1
García-García, L1
Slowing, K1
Fernández-Carballido, A1
Deviers, A1
Ken, S1
Filleron, T1
Rowland, B1
Laruelo, A1
Catalaa, I1
Lubrano, V1
Celsis, P1
Berry, I1
Mogicato, G1
Cohen-Jonathan Moyal, E1
Laprie, A1
Mariappan, R2
Venkatraghavan, L3
Vertanian, A1
Agnihotri, S1
Cynthia, S1
Reyhani, S2
Tung, T2
Khan, OH1
Zadeh, G2
Koelsch, BL1
Reed, GD1
Keshari, KR1
Chaumeil, MM2
Gould, TW1
Ward, JH1
Rahman, R1
Zhao, HB1
Sun, QX1
Chen, XF1
Han, DY1
Zhao, SG1
Fack, F1
Keunen, O1
Golebiewska, A1
Bähr, O1
Weyerbrock, A1
Stuhr, L1
Sakariassen, PØ1
Stieber, D1
Rygh, CB1
Lund-Johansen, M1
Zheng, L1
Gottlieb, E1
Niclou, SP1
Strohbehn, G1
Coman, D1
Han, L2
Ragheb, RR1
Fahmy, TM1
Huttner, AJ1
Hyder, F1
Piepmeier, JM2
Saltzman, WM3
Zhou, J1
Di Magno, L1
Manzi, D1
D'Amico, D1
Coni, S1
Macone, A1
Infante, P1
Di Marcotullio, L1
De Smaele, E1
Ferretti, E1
Screpanti, I1
Agostinelli, E1
Gulino, A1
Canettieri, G1
Zembko, I1
Ahmed, I1
Farooq, A1
Dail, J1
Tawari, P2
Wang, W2
Mcconville, C2
Kuo, YC1
Chen, YC1
Householder, KT2
DiPerna, DM1
Chung, EP1
Wohlleb, GM1
Dhruv, HD1
Berens, ME1
Sirianni, RW2
Harris, LM2
Tunariu, N1
Messiou, C3
Hughes, J1
Wallace, T1
DeSouza, NM3
Payne, GS3
Naz, A1
Thompson, DH1
Irudayaraj, J1
Wang, L2
Hao, Y2
Zhao, Y2
Meng, D2
Li, D2
Shi, J2
Zhang, Z3
Zhang, Y2
Grabacka, M1
Waligorski, P1
Zapata, A1
Blake, DA1
Wyczechowska, D1
Wilk, A1
Rutkowska, M1
Vashistha, H1
Ayyala, R1
Ponnusamy, T1
John, VT1
Culicchia, F1
Wisniewska-Becker, A1
Reiss, K1
Bharadwaj, S2
Ebinu, J1
Meng, Y1
Khan, O1
Bernstein, M1
Zhang, B1
Song, J1
Yang, X1
Jacobson, O1
Huang, P1
Sun, X2
Lin, L1
Yan, X1
Niu, G1
Ma, Q1
Tamborini, M1
Locatelli, E1
Rasile, M1
Monaco, I1
Rodighiero, S1
Corradini, I1
Franchini, MC1
Passoni, L1
Matteoli, M1
Wang, AM1
Leung, GK1
Kiang, KM1
Chan, D1
Cao, P1
Wu, EX1
Park, JM1
Josan, S1
Hurd, RE1
Mayer, D1
Recht, LD1
Pichumani, K1
Mashimo, T2
Vemireddy, V2
Kovacs, Z1
Ratnakar, J1
Mickey, B2
Malloy, CR2
DeBerardinis, RJ2
Maher, EA2
Saucier-Sawyer, JK1
Seo, YE1
Gaudin, A1
Quijano, E1
Song, E1
Sawyer, AJ2
Deng, Y1
Huttner, A1
Giampà, M1
Lissel, MB1
Patschkowski, T1
Fuchser, J1
Hans, VH1
Gembruch, O1
Bednarz, H1
Niehaus, K1
Radoul, M1
Najac, C1
Eriksson, P1
Blough, MD1
Chesnelong, C1
Cairncross, JG1
Landheer, K1
Sahgal, A1
Myrehaug, S1
Chen, AP3
Cunningham, CH1
Graham, SJ1
Sambade, M1
Deal, A1
Schorzman, A1
Luft, JC1
Bowerman, C1
Chu, K1
Karginova, O1
Swearingen, AV1
Zamboni, W1
DeSimone, J1
Anders, CK1
Tseng, YY2
Su, CH1
Yang, ST1
Huang, YC1
Lee, WH1
Wang, YC1
Liu, SJ2
Cairns, GS1
Macdonald, A1
Saran, F1
Roldan-Valadez, E1
Rios, C1
Motola-Kuba, D1
Matus-Santos, J1
Villa, AR1
Moreno-Jimenez, S1
Zeng, F1
Jin, H1
Xu, Q1
Huang, Y1
Zou, L1
Tao, Y1
Payne, G1
Do, L1
Thomas, T1
Rodriguez, J1
Dou, H1
Xu, Y1
Yi, C1
Tivnan, A1
Heilinger, T1
Ramsey, JM1
O'Connor, G1
Pokorny, JL1
Sarkaria, JN1
Stringer, BW1
Day, BW1
Boyd, AW1
Kim, EL1
Lode, HN1
Cryan, SA1
Prehn, JH1
Medina, DX1
Ceton, R1
Kovalik, T1
Heffernan, JM1
Shankar, RV1
Bowser, RP1
Wechsler-Reya, RJ1
Sankar, T1
Caramanos, Z2
Assina, R1
Villemure, JG2
Leblanc, R2
Langleben, A1
Arnold, DL3
Preul, MC2
Esther Gil-Alegre, M1
González-Alvarez, I1
Gutiérrez-Paúls, L1
Torres-Suárez, AI1
Lindvall, P1
Roslin, M1
Crawford, FW1
Khayal, IS1
McGue, C1
Saraswathy, S1
Pirzkall, A2
Cha, S3
Lamborn, KR1
Chang, SM4
Berger, MS1
Nelson, SJ9
Kang, C2
Yuan, X1
Zhong, Y1
Pu, P2
Albadany, A1
Yu, S1
Chang, J4
Sheng, J2
Benny, O2
Menon, LG1
Ariel, G1
Goren, E1
Kim, SK1
Stewman, C1
Black, PM2
Carroll, RS2
Machluf, M2
Ong, BY1
Ranganath, SH2
Lee, LY1
Lu, F1
Lee, HS1
Sahinidis, NV1
Laquintana, V1
Denora, N1
Musacchio, T1
Lasorsa, M1
Latrofa, A1
Trapani, G1
Rodrigues, TB1
Yurt, A1
Demircan, N1
Selçuki, M1
Ertürk, AR1
Turan, Y1
Atçi, B1
Ozener, V1
Kee, I1
Krantz, WB1
Zierhut, ML2
Ozturk-Isik, E2
Kasperczyk, J1
Stoklosa, K1
Dobrzynski, P1
Stepien, K1
Kaczmarczyk, B1
Dzierzega-Lecznar, A1
Nakajima, T1
Kumabe, T2
Kanamori, M1
Saito, R1
Tashiro, M1
Watanabe, M1
Tominaga, T2
Blamek, S1
Wydmański, J1
Sokół, M1
Matulewicz, L1
Boguszewicz, L1
Zhang, YH2
Liu, JM2
Yue, ZJ2
Ren, WH1
Yan, CH1
Qian, XM1
Long, LX1
He, B1
Yuan, XB1
Kang, CS1
Betbeder, D2
Pu, PY1
Girard, N1
Roger, M1
Clavreul, A2
Venier-Julienne, MC2
Passirani, C3
Sindji, L1
Schiller, P1
Montero-Menei, C1
Menei, P3
Tang, GS1
Ozeki, T3
Hashizawa, K3
Kaneko, D3
Imai, Y3
Okada, H3
Cucullo, L2
Marchi, N1
Hossain, M1
Janigro, D2
Cırpanlı, Y1
Allard, E1
Bilensoy, E1
Lemaire, L2
Calış, S1
Benoit, JP6
Tahara, K1
Kato, Y1
Yamamoto, H1
Kreuter, J1
Kawashima, Y1
Menuel, C1
Vallée, JN2
Françoise, JP2
Capelle, L1
Habas, C1
De Marco, G1
Chiras, J1
Costalat, R3
Day, SE1
Kettunen, MI1
Cherukuri, MK1
Mitchell, JB1
Lizak, MJ1
Morris, HD1
Koretsky, AP1
Brindle, KM1
Grillon, E1
Farion, R2
Fablet, K1
De Waard, M1
Tse, CM1
Donowitz, M1
Rémy, C5
Coles, JA2
Takenaka, S1
Shinoda, J1
Asano, Y1
Aki, T1
Miwa, K1
Ito, T1
Yokoyama, K1
Iwama, T1
Eloqayli, H1
Melø, TM1
Haukvik, A1
Sonnewald, U1
Ozawa, T1
James, CD1
Colen, CB1
Shen, Y1
Ghoddoussi, F1
Yu, P1
Francis, TB1
Koch, BJ1
Monterey, MD1
Galloway, MP1
Sloan, AE1
Mathupala, SP1
Wan, Y1
Mahmood, MA1
Li, N1
Allen, PB1
Kim, YT1
Bachoo, R1
Ellington, AD1
Iqbal, SM1
Goidts, V1
Bageritz, J1
Puccio, L1
Nakata, S1
Zapatka, M1
Barbus, S1
Toedt, G1
Campos, B1
Korshunov, A1
Momma, S1
Van Schaftingen, E1
Reifenberger, G1
Herold-Mende, C1
Lichter, P1
Radlwimmer, B1
Kim, TH1
Jeong, YI1
Jin, SG1
Pei, J1
Jung, TY1
Moon, KS1
Kim, IY1
Kang, SS1
Jung, S1
Paillard, A1
Morille, M1
Garcion, E2
Tagami, T2
Marin-Valencia, I1
Cho, SK1
Rakheja, D1
Hatanpaa, KJ1
Kapur, P1
Jindal, A1
Good, LB1
Raisanen, J1
Takahashi, M1
Togao, O1
Pascual, JM1
Almouazen, E1
Bourgeois, S1
Boussaïd, A1
Valot, P1
Malleval, C1
Fessi, H1
Nataf, S1
Briançon, S1
Ling, Y1
Wei, K1
Zou, F1
Zhong, S1
McLean, MA2
Sun, A1
Bradstreet, TE1
Schaeffer, AK1
Iannone, R1
Herman, G1
Railkar, RA1
Joubert, I1
Gillard, JH1
Price, SJ1
Griffiths, JR2
Chirasani, SR1
Leukel, P1
Gottfried, E1
Hochrein, J1
Stadler, K1
Neumann, B1
Oefner, PJ1
Gronwald, W1
Bogdahn, U1
Hau, P1
Kreutz, M1
Grauer, OM1
Wang, H1
Su, W1
Liao, Z1
Wang, G1
Zadran, S1
Amighi, A1
Otiniano, E1
Wong, K1
Zadran, H1
Callewaert, M1
Dukic, S1
Van Gulick, L1
Vittier, M1
Gafa, V1
Andry, MC1
Molinari, M1
Roullin, VG2
Yang, W1
Cao, Y1
Zheng, Y1
Bu, W1
Zhang, L1
You, MJ1
Koh, MY1
Cote, G1
Aldape, K1
Verma, IM1
Chiao, PJ1
Lu, Z1
Bebawy, JF1
Ramaiah, VK1
Zeeni, C1
Hemmer, LB1
Koht, A1
Gupta, DK1
Liao, JY1
Chen, WA1
Kao, YC1
Lahutte-Auboin, M1
Caivano, R1
Lotumolo, A1
Rabasco, P1
Zandolino, A1
D'Antuono, F1
Villonio, A1
Lancellotti, MI1
Macarini, L1
Cammarota, A1
Arefyeva, IA1
Semenova, JB1
Zubairaev, MS1
Kondrasheva, EA1
Moshkin, AV1
Nakaiso, M1
Uno, M2
Harada, M2
Kageji, T1
Takimoto, O1
Nagahiro, S1
Rock, JP2
Hearshen, D2
Scarpace, L2
Croteau, D2
Gutierrez, J2
Fisher, JL2
Rosenblum, ML1
Mikkelsen, T2
McAllister, MS1
Kight, K1
Krizanac-Bengez, L1
Marroni, M1
Mayberg, MR1
Stanness, KA1
Walenta, S1
Schroeder, T1
Mueller-Klieser, W1
Howe, FA1
Barton, SJ1
Cudlip, SA1
Stubbs, M1
Saunders, DE1
Murphy, M1
Wilkins, P1
Opstad, KS1
Doyle, VL1
Bell, BA1
Bulakbasi, N2
Kocaoglu, M2
Ors, F1
Tayfun, C1
Uçöz, T1
Tan, WH1
Wang, F1
Lee, T1
Aubert, A1
Duffau, H1
Benali, H1
Rutkowski, T1
Tarnawski, R1
Sokol, M1
Maciejewski, B1
Hwang, YH1
Suh, CK1
Park, SP1
Simonetti, AW1
Melssen, WJ1
van der Graaf, M1
Postma, GJ1
Buydens, LM1
Kimura, T1
Sako, K1
Tanaka, K1
Gotoh, T1
Yoshida, H1
Aburano, T1
Tanaka, T1
Arai, H1
Nakada, T1
Chan, AA1
Lau, A1
Verhey, LJ1
Larson, D2
McDermott, MW1
Dillon, WP2
Brennan, L1
Hewage, C1
Malthouse, JP1
McBean, GJ1
McKnight, TR1
Hérigault, G2
Zoula, S1
Décorps, M3
Ziegler, A4
Astrakas, LG1
Zurakowski, D1
Tzika, AA2
Zarifi, MK1
Anthony, DC1
De Girolami, U1
Tarbell, NJ1
Chernov, MF3
Kubo, O2
Hayashi, M3
Izawa, M3
Maruyama, T1
Usukura, M2
Ono, Y4
Hori, T3
Takakura, K1
Izumiyama, H1
Abe, T1
Tanioka, D1
Fukuda, A1
Kunii, N1
Abe, K1
Duvshani-Eshet, M1
Cargioli, T1
Bello, L1
Li, X1
Graves, EE2
Crawford, F1
Jenkinson, MD1
Smith, TS1
Joyce, K1
Fildes, D1
du Plessis, DG1
Warnke, PC1
Walker, C1
Matsumura, A1
Isobe, T1
Takano, S1
Kawamura, H1
Anno, I1
Chae, GS1
Lee, JS1
Kim, SH2
Seo, KS1
Kim, MS1
Lee, HB1
Khang, G1
Xie, J2
Yamasaki, F1
Takaba, J1
Ohtaki, M1
Abe, N1
Kajiwara, Y1
Saito, T1
Yoshioka, H1
Hama, S1
Akimitsu, T1
Sugiyama, K1
Arita, K1
Kurisu, K1
Balmaceda, C1
Critchell, D1
Mao, X1
Cheung, K1
Pannullo, S1
DeLaPaz, RL1
Shungu, DC1
Yamamoto, T1
Pulkkinen, J1
Häkkinen, AM1
Lundbom, N2
Paetau, A1
Kauppinen, RA1
Hiltunen, Y1
Elkharraz, K1
Faisant, N1
Guse, C1
Siepmann, F1
Arica-Yegin, B1
Oger, JM1
Gust, R1
Goepferich, A1
Siepmann, J1
Di Costanzo, A2
Scarabino, T2
Trojsi, F2
Giannatempo, GM1
Popolizio, T2
Catapano, D1
Bonavita, S2
Maggialetti, N1
Tosetti, M2
Salvolini, U1
d'Angelo, VA1
Tedeschi, G2
Sapin, A1
Schirmer, T2
Lechner, SM1
Zeng, QS1
Li, CF1
Zhen, JH1
Feng, DC1
Cianfoni, A1
Niku, S1
Imbesi, SG1
Spagnolo, A1
Grant, EN1
Glick, R1
Lichtor, T1
Feinstein, DL1
Dong, Y1
Feng, SS1
Lupo, JM1
Sanal, HT1
Onguru, O1
Chen, L1
Zacharia, TT1
Law, M1
Naidich, TP1
Leeds, NE1
Poptani, H1
Gupta, RK1
Roy, R1
Pandey, R1
Jain, VK1
Chhabra, DK1
Boisdron-Celle, M1
Kuroda, R1
Akai, F1
Iwasaki, H1
Nakatani, J1
Uchiyama, T1
Ioku, M1
Kaetsu, I1
Duyn, JH2
Frank, JA2
Moonen, CT1
Usenius, JP1
Ben-Yoseph, O2
Kingsley, PB1
Ross, BD3
Heesters, MA2
Kamman, RL2
Mooyaart, EL1
Go, KG2
Barker, PB1
Blackband, SJ1
Chatham, JC1
Soher, BJ1
Samphilipo, MA1
Magee, CA1
Hilton, JD1
Strandberg, JD1
Anderson, JH1
Le Fur, Y1
Bourgeois, D1
Heindel, W2
Kugel, H2
Lanfermann, H1
Landwehr, P1
Krahe, T1
Lackner, K1
Laws, ER1
Collins, DL1
Olivier, A1
Pokrupa, R1
Shimizu, H1
Kayama, T1
Hara, K1
Sato, K1
Arai, N1
Fujiwara, S1
Yoshimoto, T1
Dunn, RS2
Ball, WS2
Sijens, PE1
Vecht, CJ1
Levendag, PC1
van Dijk, P1
Oudkerk, M1
Siderowf, AD1
Balcer, LJ1
Kenyon, LC1
Nei, M1
Raps, EC1
Galetta, SL1
Staub, F1
Winkler, A1
Haberstok, J1
Plesnila, N1
Peters, J1
Chang, RC1
Kempski, O1
Baethmann, A1
Terpstra, M2
High, WB2
Luo, Y1
de Graaf, RA1
Merkle, H3
Garwood, M3
Haghighat, N1
McCandless, DW1
Tomoi, M1
Kimura, H1
Yoshida, M1
Itoh, S1
Kawamura, Y1
Hayashi, N1
Yamamoto, K1
Kubota, T1
Ishii, Y1
Kong, Q1
Kleinschmidt-Demasters, BK1
Lillehei, KO1
Raman, R2
Alger, JR3
Di Chiro, G2
Krikke, AP1
Estève, F1
Rubin, C1
Grand, S1
Kolodié, H1
Le Bas, JF1
Lyons, JC1
Song, CW1
Chang, KH1
Song, IC1
Han, MH1
Kim, HD1
Seong, SO1
Jung, HW1
Han, MC1
Hwang, JH1
Egnaczyk, GF1
Ballard, E1
Holland, SK1
Waldrop, SM1
Davis, PC1
Padgett, CA1
Shapiro, MB1
Morris, R1
Star-Lack, J1
Spielman, D1
Adalsteinsson, E1
Terris, DJ1
Brooks, SE1
Gu, X1
Kaufmann, PM1
Marcus, DM1
Caldwell, RB1
Mescher, M1
DelaBarre, L1
Meyerand, ME1
Pipas, JM1
Mamourian, A1
Tosteson, TD1
Dunn, JF1
Dezortová, M1
Hájek, M1
Cáp, F1
Babis, M1
Tichý, M1
Vymazal, J1
Mairs, RJ1
Wideman, CL1
Angerson, WJ1
Whateley, TL1
Reza, MS1
Reeves, JR1
Robertson, LM1
Neshasteh-Riz, A1
Rampling, R1
Owens, J1
Allan, D1
Graham, DI1
Ricci, PE1
Pitt, A1
Keller, PJ1
Coons, SW1
Heiserman, JE1
Schaffranietz, L2
Heinke, W2
Rudolph, C2
Olthoff, D2
Behrens, PF1
Langemann, H1
Strohschein, R1
Draeger, J1
Hennig, J1
Wilken, B1
Dechent, P1
Herms, J1
Maxton, C1
Markakis, E1
Hanefeld, F1
Frahm, J2
Darbin, O1
Lonjon, M1
Quentien, MH1
Michiels, JF1
Grellier, P1
Negrin, J1
Rostain, JC1
Risso, JJ1
Verhey, L1
McDermott, M1
Prados, MD1
Son, BC1
Kim, MC1
Choi, BG1
Kim, EN1
Baik, HM1
Choe, BY1
Naruse, S1
Kang, JK1
Hall, WA1
Martin, AJ1
Truwit, CL1
von Kienlin , M1
Ishimaru, H1
Morikawa, M1
Iwanaga, S1
Kaminogo, M1
Ochi, M1
Hayashi, K1
Ballesteros, P1
Bouzier-Sore, AK1
Canioni, P1
Merle, M1
Auer, DP1
Gössl, C1
Czisch, M1
de Vries, J1
Thijssen, WA1
Snels, SE1
Menovsky, T1
Peer, NG1
Lamers, KJ1
Hong, F1
Hisaoka, S1
Nishitani, H1
Matsuda, T1
Deverre, JR1
Hindré, F1
Vienet, R1
Bernsen, HJ1
van der Kogel, AJ1
van Vaals, JJ1
Prick, MJ1
Poels, EF1
Meyer, J1
Grotenhuis, JA1
Fulham, MJ1
Bizzi, A1
Dietz, MJ1
Shih, HH1
Sobering, GS1
Dwyer, AJ1
Matthews, PM1
Francis, GS1
O'Connor, J1
Antel, JP1
Herholz, K1
Luyten, PR1
denHollander, JA1
Pietrzyk, U1
Voges, J1
Friedmann, G1
Heiss, WD1
Hendrich, K1
Staewen, RS1
Henriksen, O1
Wieslander, S1
Gjerris, F1
Jensen, KM1
Sotak, CH1
Lomneth, R1
Medrano, S1
Gruenstein, EI1
Bruhn, H1
Gyngell, ML1
Merboldt, KD1
Hänicke, W1
Sauter, R1
Hamburger, C1
Palmer, GC1
Paschen, W3
Djuricic, B1
Mies, G2
Schmidt-Kastner, R1
Linn, F1
Hossmann, KA1
Szabo, L1
Dolan, E1
Wechsler, W1

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Relationship of Anesthesia Method With Serum Lactate Level in Craniotomies[NCT05145049]110 participants (Actual)Observational [Patient Registry]2021-11-01Completed
Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway (HP FFF)[NCT03480594]30 participants (Anticipated)Observational2018-10-01Enrolling by invitation
Treatment Development of Triheptanoin for Glucose Transporter Type I Deficiency[NCT02021526]Phase 1/Phase 20 participants (Actual)Interventional2015-12-31Withdrawn (stopped due to NIH funding resulted in new clinical trial)
Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism[NCT01138813]8 participants (Actual)Observational2009-03-31Completed
Comparison of Mannitol Alone Versus Different Doses of Mannitol in Combination With Furosemide on Brain Relaxation in Supratentorial Mass Resection Surgery[NCT02712476]47 participants (Actual)Interventional2013-07-31Completed
Study of Clinical Biomarkers in Human Health and Disease (Healthiomics)[NCT05106725]3,500 participants (Anticipated)Observational2021-10-11Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

15 reviews available for lactic acid and Brain Neoplasms

ArticleYear
Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform.
    Molecules (Basel, Switzerland), 2023, Jan-14, Volume: 28, Issue:2

    Topics: Blood-Brain Barrier; Brain Neoplasms; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Nan

2023
Conventional and Advanced MRI Techniques in the Evaluation of Primary CNS Lymphoma.
    Seminars in ultrasound, CT, and MR, 2023, Volume: 44, Issue:3

    Topics: Brain Neoplasms; Humans; Lactic Acid; Lymphoma; Magnetic Resonance Imaging

2023
New metabolic imaging tools in neuro-oncology.
    Current opinion in neurology, 2019, Volume: 32, Issue:6

    Topics: Brain Neoplasms; Deuterium; Glioblastoma; Glycolysis; Humans; Lactic Acid; Medical Oncology; Multimo

2019
The Acidic Brain-Glycolytic Switch in the Microenvironment of Malignant Glioma.
    International journal of molecular sciences, 2021, May-24, Volume: 22, Issue:11

    Topics: Animals; Brain; Brain Chemistry; Brain Neoplasms; Carbonic Anhydrases; Glioma; Glycolysis; Humans; H

2021
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
    Current medicinal chemistry, 2013, Volume: 20, Issue:17

    Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Drug Carriers; Enzyme Replacement Therapy; Genetic Th

2013
Lactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas.
    Current cancer drug targets, 2016, Volume: 16, Issue:5

    Topics: Animals; Brain Neoplasms; Carbonic Anhydrases; Glioblastoma; Glycolysis; Humans; Hydrogen-Ion Concen

2016
[Magnetic resonance spectroscopy for cerebral imaging].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17, Issue:6

    Topics: Apoptosis; Aspartic Acid; Asphyxia Neonatorum; Biomarkers, Tumor; Brain; Brain Diseases; Brain Disea

2010
3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
    The International journal of neuroscience, 2013, Volume: 123, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Diagnosis, Differ

2013
Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.
    Seminars in oncology, 2004, Volume: 31, Issue:5

    Topics: Alanine; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Glioma; Glutamic Acid; Glutamine; Humans

2004
[MRS for diagnosis of brain tumors].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 9

    Topics: Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Humans; Image Enhancement; Lactic Acid;

2005
Proton MR spectroscopy of the brain at 3 T: an update.
    European radiology, 2007, Volume: 17, Issue:7

    Topics: Artifacts; Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Cerebral Cortex; Choline; Creatine

2007
New methods for direct delivery of chemotherapy for treating brain tumors.
    The Yale journal of biology and medicine, 2006, Volume: 79, Issue:3-4

    Topics: Antineoplastic Agents; Biocompatible Materials; Brain Neoplasms; Clinical Trials as Topic; Drug Carr

2006
Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas.
    AJNR. American journal of neuroradiology, 1998, Volume: 19, Issue:3

    Topics: Aspartic Acid; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Choline; Humans; Infant; Lacti

1998
Image-guided 1H NMR spectroscopical and histological characterization of a human brain tumor model in the nude rat; a new approach to monitor changes in tumor metabolism.
    Journal of neuro-oncology, 1992, Volume: 13, Issue:2

    Topics: Animals; Aspartic Acid; Brain Neoplasms; Choline; Energy Metabolism; Glioblastoma; Humans; Lactates;

1992
Cyclic nucleotides in stroke and related cerebrovascular disorders.
    Life sciences, 1985, May-27, Volume: 36, Issue:21

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenosine; Adenylyl Cyclas

1985

Trials

5 trials available for lactic acid and Brain Neoplasms

ArticleYear
Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    International journal of radiation oncology, biology, physics, 2014, Oct-01, Volume: 90, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Crea

2014
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.
    Journal of neuro-oncology, 2008, Volume: 90, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Dis

2008
The effect of furosemide on intravascular volume status and electrolytes in patients receiving mannitol: an intraoperative safety analysis.
    Journal of neurosurgical anesthesiology, 2013, Volume: 25, Issue:1

    Topics: Adult; Aged; Arterial Pressure; Blood Volume; Brain Neoplasms; Crystalloid Solutions; Diuretics; Dou

2013
The origin of lactate in peritumoral edema as measured by proton-magnetic resonance spectroscopic imaging.
    Acta neurochirurgica. Supplement, 1997, Volume: 70

    Topics: Brain Edema; Brain Neoplasms; Glioma; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Protons

1997
[Is the combination of nitrous oxide and hyperventilation in elective neurosurgical operations useful?].
    Anaesthesiologie und Reanimation, 2000, Volume: 25, Issue:4

    Topics: Adult; Aged; Anesthesia, General; Brain; Brain Neoplasms; Carbon Dioxide; Female; Humans; Lactic Aci

2000

Other Studies

249 other studies available for lactic acid and Brain Neoplasms

ArticleYear
NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma.
    BMC cancer, 2021, Nov-05, Volume: 21, Issue:1

    Topics: Adenosine Triphosphate; Animals; Blotting, Western; Brain; Brain Neoplasms; Cell Line, Tumor; Forkhe

2021
Relationship of Carbohydrate Metabolism and Molecular Genetic Markers in Gliomas with Different Degree of Anaplasia.
    Bulletin of experimental biology and medicine, 2021, Volume: 172, Issue:1

    Topics: Adult; Anaplasia; Biomarkers, Tumor; Brain Chemistry; Brain Neoplasms; Carbohydrate Metabolism; DNA

2021
PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells.
    Cells, 2021, 11-07, Volume: 10, Issue:11

    Topics: Brain Neoplasms; Cell Line, Tumor; Forkhead Box Protein O1; Gene Expression Regulation, Neoplastic;

2021
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma.
    Cancer immunology, immunotherapy : CII, 2023, Volume: 72, Issue:1

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Hedgehog Proteins; Humans; Insulin-Like Gr

2023
Hyperlactatemia associated with elective tumor craniotomy: Protocol for an observational study of pathophysiology and clinical implications.
    PloS one, 2022, Volume: 17, Issue:7

    Topics: Brain Neoplasms; Craniotomy; Humans; Hyperlactatemia; Insulin Resistance; Lactic Acid; Observational

2022
Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis.
    EMBO molecular medicine, 2022, 12-07, Volume: 14, Issue:12

    Topics: Animals; Brain Neoplasms; Glioblastoma; Lactate Dehydrogenases; Lactic Acid; Metabolomics; Mice

2022
Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Brain Neoplasms; CD8-Positive T-Lymphocytes; Glioblastoma; Humans; Immunosuppressive Agents; Lactic

2023
[Lactate-induced up-regulation of PLEKHA4 promotes proliferation and apoptosis of human glioma cells].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023, Jul-20, Volume: 43, Issue:7

    Topics: Animals; Apoptosis; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Gene Expres

2023
The Warburg effect in patients with brain tumors: a comprehensive analysis of clinical significance.
    Journal of neuro-oncology, 2023, Volume: 165, Issue:1

    Topics: Brain Neoplasms; Clinical Relevance; Humans; Hyperlactatemia; Lactic Acid; Retrospective Studies

2023
Association between preoperative serum lactate concentrate with tumor cell proliferative index in primary brain tumor.
    Journal of neurosurgical sciences, 2022, Volume: 66, Issue:2

    Topics: Brain Neoplasms; Cross-Sectional Studies; Glioma; Humans; Ki-67 Antigen; Lactic Acid; Meningeal Neop

2022
Serum lactate levels are associated with glioma malignancy grade.
    Clinical neurology and neurosurgery, 2019, Volume: 186

    Topics: Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Glioma; Humans; Lactic Acid; Male; Middle Aged; Neo

2019
High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.
    Cell biology international, 2020, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aldehyde Oxidoreductases; Animals; Apoptosis; Biomarkers, Tumor; Brain Neoplasms;

2020
Metabolic response patterns in brain microdialysis fluids and serum during interstitial cisplatin treatment of high-grade glioma.
    British journal of cancer, 2020, Volume: 122, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brain; Brain Neoplasms; Cisplatin; Female; Gl

2020
miR-128-3p contributes to mitochondrial dysfunction and induces apoptosis in glioma cells via targeting pyruvate dehydrogenase kinase 1.
    IUBMB life, 2020, Volume: 72, Issue:3

    Topics: Adenosine Triphosphate; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Gene Expre

2020
Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model.
    PloS one, 2019, Volume: 14, Issue:12

    Topics: Animals; Antineoplastic Agents, Immunological; Bicarbonates; Biomarkers; Brain; Brain Neoplasms; Gli

2019
A New Pathway Promotes Adaptation of Human Glioblastoma Cells to Glucose Starvation.
    Cells, 2020, 05-18, Volume: 9, Issue:5

    Topics: Adaptation, Physiological; Benzimidazoles; Brain Neoplasms; Cell Line, Tumor; Endocytosis; Glioblast

2020
Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI.
    Theranostics, 2020, Volume: 10, Issue:16

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevacizumab; Brain; Brain Neopla

2020
Lactate as clinical tumour biomarker: Optimization of lactate detection and quantification in MR spectroscopic imaging of glioblastomas.
    European journal of radiology, 2020, Volume: 130

    Topics: Adult; Aged; Biomarkers, Tumor; Brain; Brain Neoplasms; Feasibility Studies; Female; Glioblastoma; H

2020
Different Mechanisms Underlie the Metabolic Response of GBM Stem-Like Cells to Ionizing Radiation: Biological and MRS Studies on Effects of Photons and Carbon Ions.
    International journal of molecular sciences, 2020, Jul-21, Volume: 21, Issue:14

    Topics: Brain Neoplasms; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; gamma-Aminobutyric Acid; Gliobla

2020
Lactate induced up-regulation of KLHDC8A (Kelch domain-containing 8A) contributes to the proliferation, migration and apoptosis of human glioma cells.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:20

    Topics: Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Move

2020
Intratumoral Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers.
    International journal of molecular sciences, 2020, Aug-29, Volume: 21, Issue:17

    Topics: Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Disease Progression; Epithelial-M

2020
Non-invasive assessment of telomere maintenance mechanisms in brain tumors.
    Nature communications, 2021, 01-04, Volume: 12, Issue:1

    Topics: Alanine; Animals; Biomarkers, Tumor; Brain Neoplasms; Carbon Isotopes; Cell Line, Tumor; Genetic Eng

2021
Partial differential model of lactate neuro-energetics: analytic results and numerical simulations.
    Mathematical medicine and biology : a journal of the IMA, 2021, 06-15, Volume: 38, Issue:2

    Topics: Brain Neoplasms; Diffusion; Humans; Kinetics; Lactic Acid; Models, Biological; Models, Theoretical

2021
Hyperpolarized
    Scientific reports, 2021, 03-11, Volume: 11, Issue:1

    Topics: Aerobiosis; Animals; Aspartic Acid; Brain Neoplasms; Carbon Isotopes; Cell Line, Tumor; Glioblastoma

2021
Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.
    World neurosurgery, 2021, Volume: 153

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherap

2021
Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastoma.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, 05-28, Volume: 254

    Topics: Adipocytes; Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Brain Neoplas

2017
Age, choline-to-N-acetyl aspartate, and lipids-lactate-to-creatine ratios assemble a significant Cox's proportional-hazards regression model for survival prediction in patients with high-grade gliomas.
    The British journal of radiology, 2017, Volume: 90, Issue:1075

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Glioma; Humans; Lactic Acid; Lipids; Magnetic Res

2017
Intraoperative serum lactate is not a predictor of survival after glioblastoma surgery.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2017, Volume: 43

    Topics: Adult; Aged; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Lactic Acid; Male

2017
Upregulation of mitochondrial NAD
    Experimental & molecular medicine, 2017, 06-09, Volume: 49, Issue:6

    Topics: Aging; Animals; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Colony-Forming Units Assay;

2017
In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cells.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor

2017
Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk.
    Molecular carcinogenesis, 2017, Volume: 56, Issue:12

    Topics: Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Culture Med

2017
The Significance of Lactate and Lipid Peaks for Predicting Primary Neuroepithelial Tumor Grade with Proton MR Spectroscopy.
    Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 2018, Jul-10, Volume: 17, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Female; Humans; Lactic Acid; Lipid Metabolism; Lipids; Magnetic Resona

2018
A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma.
    Journal of translational medicine, 2017, 10-18, Volume: 15, Issue:1

    Topics: Amino Acid Sequence; Brain Neoplasms; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Fluore

2017
Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
    Journal of neurochemistry, 2018, Volume: 144, Issue:4

    Topics: Animals; Antimetabolites; Antineoplastic Agents, Immunological; Bevacizumab; Brain Neoplasms; Cell D

2018
Online
    NMR in biomedicine, 2018, Volume: 31, Issue:2

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Disease Models, Animal; Female; Glioma; Lactic Acid

2018
Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment.
    International journal of pharmaceutics, 2018, Jul-10, Volume: 545, Issue:1-2

    Topics: Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Cell P

2018
Comparison between cerebrospinal fluid and serum lactate concentrations in neurologic dogs with and without structural intracranial disease.
    Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 2018, Volume: 82, Issue:2

    Topics: Animals; Brain Neoplasms; Cysts; Dog Diseases; Dogs; Epilepsy; Lactic Acid; Meningoencephalitis; Oti

2018
Measuring the lactate-to-creatine ratio via
    Cellular & molecular biology letters, 2018, Volume: 23

    Topics: Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Creatine; DNA Damage; Electrop

2018
Coordinated autophagy modulation overcomes glioblastoma chemoresistance through disruption of mitochondrial bioenergetics.
    Scientific reports, 2018, 07-09, Volume: 8, Issue:1

    Topics: Antineoplastic Agents; Autophagy; Autophagy-Related Protein 5; Brain Neoplasms; Cell Line, Tumor; Ce

2018
Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:1

    Topics: 4-Aminobutyrate Transaminase; Animals; Brain Neoplasms; Gene Expression Profiling; Gene Expression R

2019
Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    International journal of pharmaceutics, 2018, Sep-05, Volume: 548, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Delayed-Ac

2018
Spatially Resolved Bioenergetic and Genetic Reprogramming Through the Brain of Rats Bearing Implanted C6 Gliomas As Detected by Multinuclear High-Resolution Magic Angle Spinning and Genomic Analysis.
    Journal of proteome research, 2018, 09-07, Volume: 17, Issue:9

    Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Biopsy; Brain Neoplasms; Carbon Isotopes; Cau

2018
Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients.
    Magnetic resonance in medicine, 2019, Volume: 81, Issue:4

    Topics: Artifacts; Bicarbonates; Brain; Brain Neoplasms; Calibration; Carbon Isotopes; Carbon-13 Magnetic Re

2019
Analysis of a mathematical model for brain lactate kinetics.
    Mathematical biosciences and engineering : MBE, 2018, 10-01, Volume: 15, Issue:5

    Topics: Brain; Brain Neoplasms; Capillaries; Computer Simulation; Energy Metabolism; Glioma; Humans; Intrace

2018
Short-acquisition-time JPRESS and its application to paediatric brain tumours.
    Magma (New York, N.Y.), 2019, Volume: 32, Issue:2

    Topics: Adult; Biomarkers, Tumor; Brain; Brain Neoplasms; Child; Female; Glycine; Healthy Volunteers; Humans

2019
Development of Nanoparticles for Drug Delivery to Brain Tumor: The Effect of Surface Materials on Penetration Into Brain Tissue.
    Journal of pharmaceutical sciences, 2019, Volume: 108, Issue:5

    Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delive

2019
Dichloroacetate is an antimetabolite that antagonizes acetate and deprives cancer cells from its benefits: A novel evidence-based medical hypothesis.
    Medical hypotheses, 2019, Volume: 122

    Topics: Acetates; Acetyl Coenzyme A; Animals; Antineoplastic Agents; Brain Neoplasms; Chlorides; Dichloroace

2019
Verteporfin-Loaded Polymeric Microparticles for Intratumoral Treatment of Brain Cancer.
    Molecular pharmaceutics, 2019, 04-01, Volume: 16, Issue:4

    Topics: Animals; Brain Neoplasms; Glioblastoma; Humans; Lactic Acid; Male; Mice; Mice, Nude; Microspheres; P

2019
Nuclear Magnetic Resonance Spectroscopy to Identify Metabolite Biomarkers of Nonresponsiveness to Targeted Therapy in Glioblastoma Tumor Stem Cells.
    Journal of proteome research, 2019, 05-03, Volume: 18, Issue:5

    Topics: Antineoplastic Agents; Biomarkers, Pharmacological; Brain Neoplasms; Cell Survival; Citric Acid; Cit

2019
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI.
    Neuro-oncology, 2019, 09-06, Volume: 21, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Echo-Planar Imaging; Female; Glioma; Gl

2019
Kinetic Modeling of Hyperpolarized Carbon-13 Pyruvate Metabolism in the Human Brain.
    IEEE transactions on medical imaging, 2020, Volume: 39, Issue:2

    Topics: Brain; Brain Neoplasms; Carbon Isotopes; Echo-Planar Imaging; Humans; Image Interpretation, Computer

2020
ATM-NFκB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFα.
    Cell death & disease, 2013, May-02, Volume: 4

    Topics: Adenosine Triphosphate; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Ataxi

2013
Body mass index as a risk factor for increased serum lactate during craniotomy.
    Minerva anestesiologica, 2013, Volume: 79, Issue:10

    Topics: Adult; Aged; Blood Gas Analysis; Body Mass Index; Brain Neoplasms; Craniotomy; Female; Humans; Lacti

2013
Caloric restriction reduces edema and prolongs survival in a mouse glioma model.
    Journal of neuro-oncology, 2013, Volume: 114, Issue:1

    Topics: 3-Hydroxybutyric Acid; Animals; Brain Edema; Brain Neoplasms; Caloric Restriction; Cell Line, Tumor;

2013
Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.
    Neuro-oncology, 2013, Volume: 15, Issue:10

    Topics: Adenosine Triphosphate; Blotting, Western; Brain Neoplasms; Energy Metabolism; Glioma; Glucose; Glyc

2013
Magnetic resonance imaging spectroscopy in pediatric atypical teratoid rhabdoid tumors of the brain.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:6

    Topics: Brain; Brain Neoplasms; Child, Preschool; Choline; Chromosomal Proteins, Non-Histone; Creatine; Diag

2014
Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Animals; Brain Neoplasms; Cell Death; Cell Line, Tumor; Chemotherapy, Adjuvant; Drug Delivery System

2013
Cell culture monitoring for drug screening and cancer research: a transparent, microfluidic, multi-sensor microsystem.
    Lab on a chip, 2014, Jan-07, Volume: 14, Issue:1

    Topics: Antineoplastic Agents; Biological Transport; Biosensing Techniques; Brain Neoplasms; Cell Culture Te

2014
iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.
    Biomaterials, 2014, Volume: 35, Issue:14

    Topics: Administration, Intravenous; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Collage

2014
Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
    Pharmaceutical development and technology, 2015, Volume: 20, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Doxoru

2015
Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism.
    Cell death & disease, 2014, May-08, Volume: 5

    Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphate; Animals; Antineoplastic Agents; Apopto

2014
Double-effective chitosan scaffold-PLGA nanoparticle system for brain tumour therapy: in vitro study.
    Journal of microencapsulation, 2014, Volume: 31, Issue:7

    Topics: Antimetabolites, Antineoplastic; Brain Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Fluorou

2014
Proton T2 measurement and quantification of lactate in brain tumors by MRS at 3 Tesla in vivo.
    Magnetic resonance in medicine, 2015, Volume: 73, Issue:6

    Topics: Adult; Aged; Artifacts; Aspartic Acid; Brain Chemistry; Brain Neoplasms; Choline; Creatine; Female;

2015
New celecoxib multiparticulate systems to improve glioblastoma treatment.
    International journal of pharmaceutics, 2014, Oct-01, Volume: 473, Issue:1-2

    Topics: Animals; Brain Neoplasms; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibito

2014
Serum lactate as a potential biomarker of malignancy in primary adult brain tumours.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2015, Volume: 22, Issue:1

    Topics: Adult; Aged; Biomarkers; Brain Neoplasms; Craniotomy; Disease Progression; Female; Glycolysis; Human

2015
Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized (13) C metabolites.
    Magnetic resonance in medicine, 2015, Volume: 74, Issue:3

    Topics: Animals; Brain; Brain Neoplasms; Carbon Isotopes; Cell Line, Tumor; Diffusion Magnetic Resonance Ima

2015
Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma.
    Annals of the Royal College of Surgeons of England, 2014, Volume: 96, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Brain Neoplasms; Disease Mo

2014
Efficacy of intratumoral chemotherapy using arsenic trioxide (As2O3) sustained release tablets for the treatment of neurogliocytoma in nude mice.
    European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:17

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Delayed-Ac

2014
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.
    Acta neuropathologica, 2015, Volume: 129, Issue:1

    Topics: Adult; Aged; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain

2015
Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance.
    Journal of neuro-oncology, 2015, Volume: 121, Issue:3

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Convection; Drug Delivery Systems; Ferric Compounds

2015
Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth.
    Cell cycle (Georgetown, Tex.), 2014, Volume: 13, Issue:21

    Topics: Animals; Apoptosis; Brain Neoplasms; Cell Proliferation; Cells, Cultured; Dichloroacetic Acid; Glyco

2014
Development of disulfiram-loaded poly(lactic-co-glycolic acid) wafers for the localised treatment of glioblastoma multiforme: a comparison of manufacturing techniques.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:3

    Topics: Antineoplastic Agents; Brain Neoplasms; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell S

2015
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    International journal of pharmaceutics, 2015, Feb-01, Volume: 479, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumo

2015
Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma.
    International journal of pharmaceutics, 2015, Feb-20, Volume: 479, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Camptothecin; Drug

2015
Evaluation of lactate detection using selective multiple quantum coherence in phantoms and brain tumours.
    NMR in biomedicine, 2015, Volume: 28, Issue:3

    Topics: Brain; Brain Neoplasms; Humans; Lactic Acid; Lipids; Magnetic Resonance Imaging; Metabolome; Phantom

2015
Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide.
    Molecular pharmaceutics, 2015, Apr-06, Volume: 12, Issue:4

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Apoptosis; Azacitidine; Biocompa

2015
Single-shot single-voxel lactate measurements using FOCI-LASER and a multiple-quantum filter.
    NMR in biomedicine, 2015, Volume: 28, Issue:4

    Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Lobular; Cell Hypoxia; Choline; Female; Humans; Lactic

2015
Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles.
    Journal of drug targeting, 2015, Volume: 23, Issue:9

    Topics: Animals; Apoptosis; Brain; Brain Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Combinations; Glioma

2015
Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2015, Volume: 66, Issue:2

    Topics: Animals; Biodegradable Plastics; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Female; Fe

2015
Serum lactate as a potential biomarker of non-glial brain tumors.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2015, Volume: 22, Issue:10

    Topics: Biomarkers; Brain Neoplasms; Female; Glycolysis; Humans; Lactic Acid; Male; Neoplasm Recurrence, Loc

2015
Targeted Imaging and Chemo-Phototherapy of Brain Cancer by a Multifunctional Drug Delivery System.
    Macromolecular bioscience, 2015, Volume: 15, Issue:11

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Glioma; Humans; Lactic

2015
Ultrasmall Gold Nanorod Vesicles with Enhanced Tumor Accumulation and Fast Excretion from the Body for Cancer Therapy.
    Advanced materials (Deerfield Beach, Fla.), 2015, Sep-02, Volume: 27, Issue:33

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Gold; Humans; Kinetics; Lactic Acid; Mice; Nanotubes; Ph

2015
Hot melt extruded and injection moulded disulfiram-loaded PLGA millirods for the treatment of glioblastoma multiforme via stereotactic injection.
    International journal of pharmaceutics, 2015, Oct-15, Volume: 494, Issue:1

    Topics: Brain Neoplasms; Cell Line, Tumor; Disulfiram; Drug Carriers; Drug Delivery Systems; Freezing; Gliob

2015
A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
    ACS nano, 2016, Feb-23, Volume: 10, Issue:2

    Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Chemoradiotherapy; Chloride Channel

2016
Separation and quantification of lactate and lipid at 1.3 ppm by diffusion-weighted magnetic resonance spectroscopy.
    Magnetic resonance in medicine, 2017, Volume: 77, Issue:2

    Topics: Algorithms; Animals; Brain Chemistry; Brain Neoplasms; Cell Line, Tumor; Diffusion Magnetic Resonanc

2017
Hyperpolarized (13)C-lactate to (13)C-bicarbonate ratio as a biomarker for monitoring the acute response of anti-vascular endothelial growth factor (anti-VEGF) treatment.
    NMR in biomedicine, 2016, Volume: 29, Issue:5

    Topics: Animals; Bicarbonates; Biomarkers, Tumor; Brain Neoplasms; Carbon Isotopes; Cell Count; Cell Prolife

2016
Hepatic gluconeogenesis influences (13)C enrichment in lactate in human brain tumors during metabolism of [1,2-(13)C]acetate.
    Neurochemistry international, 2016, Volume: 97

    Topics: Acetates; Brain Neoplasms; Carbon Isotopes; Gluconeogenesis; Humans; Lactic Acid; Liver; Magnetic Re

2016
Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, 06-28, Volume: 232

    Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Convection; Drug Delivery Systems; Glioblastoma;

2016
Maleic anhydride proton sponge as a novel MALDI matrix for the visualization of small molecules (<250 m/z) in brain tumors by routine MALDI ToF imaging mass spectrometry.
    Chemical communications (Cambridge, England), 2016, Aug-14, Volume: 52, Issue:63

    Topics: Brain; Brain Neoplasms; Chlorides; Glioblastoma; Glutarates; Humans; Lactic Acid; Maleic Anhydrides;

2016
Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.
    NeuroImage. Clinical, 2016, Volume: 12

    Topics: Biomarkers, Tumor; Brain Neoplasms; Carbon-13 Magnetic Resonance Spectroscopy; Glioma; Humans; Isoci

2016
A rapid inversion technique for the measurement of longitudinal relaxation times of brain metabolites: application to lactate in high-grade gliomas at 3 T.
    NMR in biomedicine, 2016, Volume: 29, Issue:10

    Topics: Algorithms; Biomarkers, Tumor; Brain Neoplasms; Glioma; Humans; Image Enhancement; Image Interpretat

2016
Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases.
    Nanomedicine (London, England), 2016, Volume: 11, Issue:15

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tum

2016
Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes.
    Oncotarget, 2016, Sep-13, Volume: 7, Issue:37

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Brain; Brain Neoplasms; Camptoth

2016
Validating a robust double-quantum-filtered (1) H MRS lactate measurement method in high-grade brain tumours.
    NMR in biomedicine, 2016, Volume: 29, Issue:10

    Topics: Algorithms; Biomarkers, Tumor; Brain Neoplasms; Humans; Lactic Acid; Magnetic Resonance Imaging; Mol

2016
Choline-to-N-acetyl aspartate and lipids-lactate-to-creatine ratios together with age assemble a significant Cox's proportional-hazards regression model for prediction of survival in high-grade gliomas.
    The British journal of radiology, 2016, Volume: 89, Issue:1067

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biomarkers; Brain Neoplasms; Choline; Cre

2016
Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy.
    ACS applied materials & interfaces, 2016, Nov-30, Volume: 8, Issue:47

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Curcumin; Drug Delivery Systems; Glioma; Lactic Acid; Mi

2016
Serum Lactate is a Biomarker of Brain Tumor Metabolism.
    Journal of neurosurgical anesthesiology, 2017, Volume: 29, Issue:4

    Topics: Biomarkers; Brain; Brain Neoplasms; Humans; Lactates; Lactic Acid

2017
Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
    Oncotarget, 2017, Jan-24, Volume: 8, Issue:4

    Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Cell L

2017
Assessment of alterations in X-ray irradiation-induced DNA damage of glioma cells by using proton nuclear magnetic resonance spectroscopy.
    The international journal of biochemistry & cell biology, 2017, Volume: 84

    Topics: Apoptosis; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Choline; Creati

2017
Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.
    Oncotarget, 2017, Mar-07, Volume: 8, Issue:10

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Aromatase Inhibitors; Brain Neoplasms; Cell Line, Tum

2017
Optical barcoding of PLGA for multispectral analysis of nanoparticle fate in vivo.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, 05-10, Volume: 253

    Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Gene Pr

2017
Three weeks release BCNU loaded hydrophilic-PLGA microspheres for interstitial chemotherapy: Development and activity against human glioblastoma cells.
    Journal of microencapsulation, 2008, Volume: 25, Issue:8

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Survival; Drug Carriers; Gliobl

2008
Cerebral metabolism during air transport of patients after surgery for malignant glioma.
    Aviation, space, and environmental medicine, 2008, Volume: 79, Issue:7

    Topics: Air Ambulances; Brain; Brain Neoplasms; Glioma; Glucose; Glutamic Acid; Glycerol; Humans; Lactic Aci

2008
Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.
    Journal of neuro-oncology, 2009, Volume: 91, Issue:3

    Topics: Adult; Aged; Aspartic Acid; Brain Mapping; Brain Neoplasms; Choline; Creatine; Diagnosis, Differenti

2009
Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles.
    Technology in cancer research & treatment, 2009, Volume: 8, Issue:1

    Topics: Animals; Brain Neoplasms; Carmustine; Cell Line, Tumor; Glioma; Lactic Acid; Male; Nanoparticles; Po

2009
Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Feb-15, Volume: 15, Issue:4

    Topics: Animals; Benzamides; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Glioma; Humans; Imatinib Mesy

2009
Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
    Biomaterials, 2009, Volume: 30, Issue:18

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Division; Cell Line, Tu

2009
Peripheral benzodiazepine receptor ligand-PLGA polymer conjugates potentially useful as delivery systems of apoptotic agents.
    Journal of controlled release : official journal of the Controlled Release Society, 2009, Aug-04, Volume: 137, Issue:3

    Topics: Acetamides; Animals; Antineoplastic Agents; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic

2009
Redox dependence and compartmentation of [13C]pyruvate in the brain of deuterated rats bearing implanted C6 gliomas.
    Journal of neurochemistry, 2009, Volume: 109 Suppl 1

    Topics: Animals; Astrocytes; Brain Chemistry; Brain Neoplasms; Carbon Isotopes; Cell Line, Tumor; Cerebral C

2009
Magnetic resonance spectroscopic imaging associated with analysis of fluid in cystic brain tumors.
    Neurological research, 2010, Volume: 32, Issue:2

    Topics: Brain Neoplasms; Cyst Fluid; Cysts; Humans; Lactic Acid; Magnetic Resonance Spectroscopy

2010
Hydrogel matrix entrapping PLGA-paclitaxel microspheres: drug delivery with near zero-order release and implantability advantages for malignant brain tumour chemotherapy.
    Pharmaceutical research, 2009, Volume: 26, Issue:9

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Calorimetry, Differential Sc

2009
(1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques.
    Journal of magnetic resonance imaging : JMRI, 2009, Volume: 30, Issue:3

    Topics: Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Contrast Media; Creatine; Echo-Planar

2009
Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
    International journal of pharmaceutics, 2009, Dec-01, Volume: 382, Issue:1-2

    Topics: Animals; Antibiotics, Antineoplastic; Brain Neoplasms; Cerebrospinal Fluid; Chemistry, Pharmaceutica

2009
Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.
    Neurologia medico-chirurgica, 2009, Volume: 49, Issue:9

    Topics: Adolescent; Adult; Aged; Biomarkers; Brain; Brain Neoplasms; Carbon Radioisotopes; Choline; Diagnosi

2009
Magnetic resonance spectroscopic evaluation of brain tissue metabolism after irradiation for pediatric brain tumors in long-term survivors: a report of two cases.
    Acta neurochirurgica. Supplement, 2010, Volume: 106

    Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Humans; Lactic Acid; Ma

2010
Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats.
    Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Dacarbazine; Glioma; In Situ Nick-End La

2011
Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma.
    Journal of materials science. Materials in medicine, 2010, Volume: 21, Issue:9

    Topics: Brain Neoplasms; Glioma; Humans; Lactic Acid; Micelles; Polyethylene Glycols; Transferrin

2010
Implementation of 3 T lactate-edited 3D 1H MR spectroscopic imaging with flyback echo-planar readout for gliomas patients.
    Annals of biomedical engineering, 2011, Volume: 39, Issue:1

    Topics: Adult; Biomarkers, Tumor; Brain Chemistry; Brain Neoplasms; Echo-Planar Imaging; Female; Glioma; Hum

2011
Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors.
    Biomaterials, 2010, Volume: 31, Issue:32

    Topics: Animals; Brain; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Membrane Permeability;

2010
Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2010, Volume: 76, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoc

2010
Treatment of rat brain tumors using sustained-release of camptothecin from poly(lactic-co-glycolic acid) microspheres in a thermoreversible hydrogel.
    Chemical & pharmaceutical bulletin, 2010, Volume: 58, Issue:9

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Delayed-Action Prep

2010
A dynamic in vitro BBB model for the study of immune cell trafficking into the central nervous system.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2011, Volume: 31, Issue:2

    Topics: Adult; Blood-Brain Barrier; Brain Neoplasms; Cells, Cultured; Central Nervous System; Cerebrovascula

2011
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
    International journal of pharmaceutics, 2011, Jan-17, Volume: 403, Issue:1-2

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; B

2011
Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
    Journal of microencapsulation, 2011, Volume: 28, Issue:1

    Topics: Antibiotics, Antineoplastic; Brain Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Cell Pro

2011
Mathematical modeling of energy metabolism and hemodynamics of WHO grade II gliomas using in vivo MR data.
    Comptes rendus biologies, 2011, Volume: 334, Issue:1

    Topics: Adolescent; Adult; Aged; Algorithms; Brain Neoplasms; Cerebrovascular Circulation; Child; Choline; F

2011
Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging.
    Magnetic resonance in medicine, 2011, Volume: 65, Issue:2

    Topics: Animals; Brain Neoplasms; Carbon Isotopes; Cell Line, Tumor; Contrast Media; Glioma; Lactic Acid; Ma

2011
The spatial organization of proton and lactate transport in a rat brain tumor.
    PloS one, 2011, Feb-24, Volume: 6, Issue:2

    Topics: Animals; Biological Transport; Brain Neoplasms; Cells, Cultured; Glioma; Ion Transport; Lactic Acid;

2011
Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.
    Brain tumor pathology, 2011, Volume: 28, Issue:3

    Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Creatine; Demyelinating Diseases; Diagnosis, Differe

2011
[2,4-(13)C]β-hydroxybutyrate metabolism in astrocytes and C6 glioblastoma cells.
    Neurochemical research, 2011, Volume: 36, Issue:8

    Topics: 3-Hydroxybutyric Acid; Animals; Aspartic Acid; Astrocytes; Brain Neoplasms; Citric Acid Cycle; Diet,

2011
Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging.
    Journal of magnetic resonance imaging : JMRI, 2011, Volume: 33, Issue:6

    Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carbon Isotopes; Cell Line, Tumor; Daca

2011
Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study.
    Neoplasia (New York, N.Y.), 2011, Volume: 13, Issue:7

    Topics: Animals; Antineoplastic Agents; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Coumaric Ac

2011
Nanotextured substrates with immobilized aptamers for cancer cell isolation and cytology.
    Cancer, 2012, Feb-15, Volume: 118, Issue:4

    Topics: Aptamers, Nucleotide; Brain Neoplasms; Cell Separation; Cells, Cultured; Cytodiagnosis; Cytological

2012
RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival.
    Oncogene, 2012, Jul-05, Volume: 31, Issue:27

    Topics: Adenosine Triphosphate; Brain Neoplasms; Cell Death; Cell Survival; Gene Expression Regulation, Neop

2012
Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Acetone; Animals; Antineoplastic Agents; Brain Neoplasms; Celecoxib; Cell Line, Tumor; Cell Movement

2011
Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.
    Pharmaceutical research, 2012, Volume: 29, Issue:6

    Topics: Adsorption; Animals; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Caveo

2012
Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
    International journal of pharmaceutics, 2012, May-10, Volume: 427, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Camptothecin; Cell Line, Tumor;

2012
Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors.
    NMR in biomedicine, 2012, Volume: 25, Issue:10

    Topics: Animals; Brain Neoplasms; Carcinoma, Renal Cell; Citric Acid Cycle; Disease Models, Animal; gamma-Am

2012
Development of a nanoparticle-based system for the delivery of retinoic acid into macrophages.
    International journal of pharmaceutics, 2012, Jul-01, Volume: 430, Issue:1-2

    Topics: Animals; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Chemical Precipitation; Chemistry,

2012
Combination therapy of surgical tumor resection with implantation of a hydrogel containing camptothecin-loaded poly(lactic-co-glycolic acid) microspheres in a C6 rat glioma model.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Combine

2012
Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
    International journal of pharmaceutics, 2012, Jul-01, Volume: 430, Issue:1-2

    Topics: Animals; Antineoplastic Agents, Alkylating; Biological Transport; Brain Neoplasms; Cell Line, Tumor;

2012
Repeatability of edited lactate and other metabolites in astrocytoma at 3T.
    Journal of magnetic resonance imaging : JMRI, 2012, Volume: 36, Issue:2

    Topics: Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Female; Humans; Lactic Acid; Magnetic Resonance Spe

2012
Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
    International journal of cancer, 2013, Feb-15, Volume: 132, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Brain Neoplasms; Cell Cycle Che

2013
Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.
    Nanoscale, 2012, Oct-21, Volume: 4, Issue:20

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Drug Carriers; Dru

2012
ENTPD5-mediated modulation of ATP results in altered metabolism and decreased survival in gliomablastoma multiforme.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:6

    Topics: Adenosine Triphosphate; Animals; Autophagy; Blotting, Western; Brain; Brain Neoplasms; Cell Prolifer

2012
Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
    Journal of biomedical materials research. Part A, 2013, Volume: 101, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival;

2013
EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
    Molecular cell, 2012, Dec-14, Volume: 48, Issue:5

    Topics: Animals; Brain Neoplasms; Carrier Proteins; Cell Line, Tumor; Cell Transformation, Neoplastic; Enzym

2012
Sustainable release of carmustine from biodegradable poly[((D,L))-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity: in vitro and in vivo studies.
    Expert opinion on drug delivery, 2013, Volume: 10, Issue:7

    Topics: Absorbable Implants; Animals; Antineoplastic Agents, Alkylating; Biocompatible Materials; Biological

2013
On a minimal model for hemodynamics and metabolism of lactate: application to low grade glioma and therapeutic strategies.
    Acta biotheoretica, 2013, Volume: 61, Issue:1

    Topics: Brain Neoplasms; Glioma; Hemodynamics; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Models,

2013
Analysis of fluid in craniopharyngioma-related cysts in children: proteins, lactate and pH.
    Acta neurochirurgica, 2002, Volume: 144, Issue:6

    Topics: Adolescent; Albumins; Blood-Brain Barrier; Brain Diseases; Brain Neoplasms; Child; Child, Preschool;

2002
Brain abscess and glioblastoma identified by combined proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging--two case reports.
    Neurologia medico-chirurgica, 2002, Volume: 42, Issue:8

    Topics: Acetates; Adult; Amino Acids; Aspartic Acid; Brain Abscess; Brain Neoplasms; Diagnosis, Differential

2002
Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
    Neurosurgery, 2002, Volume: 51, Issue:4

    Topics: Adult; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glioma; Humans; Lactic Acid; Lip

2002
A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier.
    Brain research, 2002, Oct-04, Volume: 951, Issue:2

    Topics: Algorithms; Animals; Aorta; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Capillaries; Cattle; C

2002
In regard to Tarnawski et al., IJROBP 2002;52:1271-1276.
    International journal of radiation oncology, biology, physics, 2002, Dec-01, Volume: 54, Issue:5

    Topics: Brain Neoplasms; Carcinoma, Squamous Cell; Female; Glioma; Humans; Hydrogen; Lactic Acid; Luminescen

2002
Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.
    Magnetic resonance in medicine, 2003, Volume: 49, Issue:2

    Topics: Alanine; Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Creatine; Glioblastoma; Humans; Inosi

2003
Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
    AJNR. American journal of neuroradiology, 2003, Volume: 24, Issue:2

    Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creat

2003
Computer simulation of the delivery of etanidazole to brain tumor from PLGA wafers: comparison between linear and double burst release systems.
    Biotechnology and bioengineering, 2003, May-05, Volume: 82, Issue:3

    Topics: Animals; Brain Neoplasms; Computer Simulation; Drug Delivery Systems; Drug Implants; Etanidazole; Hu

2003
Modeling of pathophysiological coupling between brain electrical activation, energy metabolism and hemodynamics: insights for the interpretation of intracerebral tumor imaging.
    Acta biotheoretica, 2002, Volume: 50, Issue:4

    Topics: Adenosine Triphosphate; Blood-Brain Barrier; Brain Neoplasms; Cerebrovascular Circulation; Energy Me

2002
1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors.
    International journal of radiation oncology, biology, physics, 2003, Aug-01, Volume: 56, Issue:5

    Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Neoplasms; Combined Modality Therapy; Female; Humans;

2003
Multifocal inflammatory leukoencephalopathy: use of thallium-201 SPECT and proton MRS.
    Journal of Korean medical science, 2003, Volume: 18, Issue:4

    Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Aspartic Acid; Axons; Biopsy; Brain; Brain

2003
A chemometric approach for brain tumor classification using magnetic resonance imaging and spectroscopy.
    Analytical chemistry, 2003, Oct-15, Volume: 75, Issue:20

    Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Neoplasms; Cerebrospinal Fluid; Choline; Creatine; Disc

2003
Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
    Journal of neurosurgery, 2004, Volume: 100, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Neoplasms; Choline; Contrast Media; Fema

2004
Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
    Journal of neurosurgery, 2004, Volume: 101, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Cohor

2004
Gliotoxins disrupt alanine metabolism and glutathione production in C6 glioma cells: a 13C NMR spectroscopic study.
    Neurochemistry international, 2004, Volume: 45, Issue:8

    Topics: Alanine; Alanine Transaminase; Brain Neoplasms; Cell Line, Tumor; Dicarboxylic Acids; Enzyme Inhibit

2004
Multi-spin-echo J-resolved spectroscopic imaging without water suppression: application to a rat glioma at 7 T.
    Magma (New York, N.Y.), 2004, Volume: 17, Issue:3-6

    Topics: Algorithms; Animals; Biomarkers, Tumor; Brain Neoplasms; Diagnosis, Computer-Assisted; Female; Gliom

2004
Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Dec-15, Volume: 10, Issue:24

    Topics: Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Femal

2004
Proton MRS of the peritumoral brain.
    Journal of the neurological sciences, 2005, Feb-15, Volume: 228, Issue:2

    Topics: Adult; Aspartic Acid; Biomarkers, Tumor; Brain; Brain Edema; Brain Neoplasms; Epilepsy; Female; Huma

2005
Clinicopathological examination of glioma by proton magnetic resonance spectroscopy background.
    Brain tumor pathology, 2004, Volume: 21, Issue:1

    Topics: Adult; Aspartic Acid; Brain Neoplasms; Choline; Female; Glioma; Humans; Lactic Acid; Magnetic Resona

2004
Early metabolic changes in metastatic brain tumors after Gamma Knife radiosurgery: 1H-MRS study.
    Brain tumor pathology, 2004, Volume: 21, Issue:2

    Topics: Aged; Aspartic Acid; Brain Neoplasms; Creatine; Female; Glycerylphosphorylcholine; Humans; Lactic Ac

2004
Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jan-15, Volume: 11, Issue:2 Pt 1

    Topics: Animals; Biocompatible Materials; Brain Neoplasms; Cattle; Coagulants; Drug Delivery Systems; Endoth

2005
Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo.
    AJNR. American journal of neuroradiology, 2005, Volume: 26, Issue:4

    Topics: Blood Volume; Brain Neoplasms; Glioma; Humans; Lactic Acid; Lipids; Magnetic Resonance Spectroscopy;

2005
MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.
    Neurology, 2005, Jun-28, Volume: 64, Issue:12

    Topics: Adult; Aged; Allelic Imbalance; Astrocytoma; Brain Neoplasms; Choline; Chromosomes, Human, Pair 1; C

2005
Non-invasive quantification of lactate by proton MR spectroscopy and its clinical applications.
    Clinical neurology and neurosurgery, 2005, Volume: 107, Issue:5

    Topics: Adult; Aged; Body Water; Brain Infarction; Brain Neoplasms; Female; Glioma; Humans; Lactic Acid; Lym

2005
Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer.
    International journal of pharmaceutics, 2005, Sep-14, Volume: 301, Issue:1-2

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Line, Tumor; Cell Survival; Dru

2005
Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.
    Pharmaceutical research, 2005, Volume: 22, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Phar

2005
Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy.
    Neurosurgical review, 2005, Volume: 28, Issue:4

    Topics: Aged; Algorithms; Brain Chemistry; Brain Neoplasms; Female; Glioblastoma; Humans; Lactic Acid; Lipid

2005
Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.
    Journal of neuro-oncology, 2006, Volume: 76, Issue:2

    Topics: Adult; Antineoplastic Agents; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Disease-Free Surviv

2006
Independent component analysis to proton spectroscopic imaging data of human brain tumours.
    European journal of radiology, 2005, Volume: 56, Issue:2

    Topics: Algorithms; Aspartic Acid; Astrocytoma; Brain Neoplasms; Cell Proliferation; Choline; Creatine; Glio

2005
Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization.
    International journal of pharmaceutics, 2006, May-18, Volume: 314, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Drug Carriers; Drug Compounding; Drug Implants;

2006
Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
    Neuroradiology, 2006, Volume: 48, Issue:9

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Contrast Media; Creatine; Diffusio

2006
Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro.
    Pharmaceutical research, 2006, Volume: 23, Issue:8

    Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Chemical Phenom

2006
Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
    International journal of clinical oncology, 2006, Volume: 11, Issue:5

    Topics: Aged; Algorithms; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Evalua

2006
Evaluation of particulate systems supporting tumor cell fractions in a preventive vaccination against intracranial rat glioma.
    Journal of neurosurgery, 2006, Volume: 105, Issue:5

    Topics: Animals; Antigens, Neoplasm; Biocompatible Materials; Brain Neoplasms; Cancer Vaccines; Cell Fractio

2006
Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    International journal of radiation oncology, biology, physics, 2007, May-01, Volume: 68, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Diffusion Magn

2007
Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
    AJNR. American journal of neuroradiology, 2007, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Demyelinating Diseases;

2007
Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes.
    Neuroscience letters, 2007, Apr-24, Volume: 417, Issue:1

    Topics: Animals; Antineoplastic Agents; Astrocytes; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Surv

2007
Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
    International journal of pharmaceutics, 2007, Sep-05, Volume: 342, Issue:1-2

    Topics: Antineoplastic Agents, Phytogenic; Brain Neoplasms; Calorimetry, Differential Scanning; Cell Surviva

2007
Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma.
    AJNR. American journal of neuroradiology, 2007, Volume: 28, Issue:8

    Topics: Adult; Aged; Brain Neoplasms; Creatine; Female; Glioma; Humans; Lactic Acid; Magnetic Resonance Imag

2007
Giant infantile gliosarcoma: magnetic resonance imaging findings.
    Journal of child neurology, 2008, Volume: 23, Issue:8

    Topics: Aspartic Acid; Brain; Brain Neoplasms; Child, Preschool; Choline; Creatinine; Female; Gliosarcoma; H

2008
Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2008, Volume: 18, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Biopsy; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differenti

2008
Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
    AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Child; Choline; Crea

1995
Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers.
    The Journal of pharmacy and pharmacology, 1995, Volume: 47, Issue:2

    Topics: Biocompatible Materials; Biodegradation, Environmental; Brain Neoplasms; Delayed-Action Preparations

1995
Interstitial chemotherapy with biodegradable ACNU pellet for glioblastoma.
    Stereotactic and functional neurosurgery, 1994, Volume: 63, Issue:1-4

    Topics: Adult; Aged; Animals; Biodegradation, Environmental; Brain Neoplasms; Drug Implants; Female; Gliobla

1994
Incorporation of lactate measurement in multi-spin-echo proton spectroscopic imaging.
    Magnetic resonance in medicine, 1995, Volume: 33, Issue:1

    Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Neoplasms; Choline; Creatine; Humans; Image Processing,

1995
[Clinical suitability of brain tumor patients for single voxel protein MR spectroscopy].
    Rontgenpraxis; Zeitschrift fur radiologische Technik, 1994, Volume: 47, Issue:7

    Topics: Aspartic Acid; Brain Neoplasms; Cell Division; Choline; Creatine; Energy Metabolism; Humans; Lactate

1994
Metabolic loss of deuterium from isotopically labeled glucose.
    Magnetic resonance in medicine, 1994, Volume: 32, Issue:3

    Topics: Animals; Brain Neoplasms; Carbon Isotopes; Cerebral Cortex; Deuterium; Gas Chromatography-Mass Spect

1994
Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy.
    Journal of neuro-oncology, 1993, Volume: 17, Issue:1

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Glioma; Humans; Lactates; Lactic Acid; Magnetic Resonance I

1993
Quantitative proton spectroscopy and histology of a canine brain tumor model.
    Magnetic resonance in medicine, 1993, Volume: 30, Issue:4

    Topics: Animals; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Dogs; Glioma; Lactates; Lactic Acid; Mag

1993
Phased spectroscopic images: application to the characterization of the 1H 1.3-ppm resonance in intracerebral tumors in the rat.
    Magnetic resonance in medicine, 1993, Volume: 29, Issue:4

    Topics: Animals; Brain; Brain Neoplasms; Fourier Analysis; Glioma; Lactates; Lactic Acid; Magnetic Resonance

1993
[Spectroscopic imaging of the brain. Examination technique and clinical applications].
    Der Nervenarzt, 1995, Volume: 66, Issue:12

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Cerebral Infarction; Choline; Creatine; Energy M

1995
Imaging brain tumors -- beyond three dimensions.
    Nature medicine, 1996, Volume: 2, Issue:3

    Topics: Aged; Alanine; Brain Neoplasms; Choline; Female; Glioblastoma; Humans; Lactates; Lactic Acid; Magnet

1996
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy.
    Nature medicine, 1996, Volume: 2, Issue:3

    Topics: Adult; Alanine; Aspartic Acid; Astrocytoma; Biomarkers; Brain; Brain Neoplasms; Choline; Creatine; D

1996
Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.
    AJNR. American journal of neuroradiology, 1996, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Energy Metabolism; Femal

1996
Intracranial tumors in children: small single-voxel proton MR spectroscopy using short- and long-echo sequences.
    Neuroradiology, 1996, Volume: 38, Issue:3

    Topics: Adolescent; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Creatinine; Female; Gl

1996
Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast.
    Investigative radiology, 1995, Volume: 30, Issue:12

    Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Energy Metabolism; Follow-Up Studies; Four

1995
Central neurogenic hyperventilation in an awake patient with a pontine glioma.
    Neurology, 1996, Volume: 46, Issue:4

    Topics: Astrocytoma; Brain Neoplasms; Cerebrospinal Fluid; Humans; Hydrogen-Ion Concentration; Hyperventilat

1996
Swelling, intracellular acidosis, and damage of glial cells.
    Acta neurochirurgica. Supplement, 1996, Volume: 66

    Topics: Acid-Base Equilibrium; Animals; Arachidonic Acid; Brain Damage, Chronic; Brain Edema; Brain Ischemia

1996
Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma.
    NMR in biomedicine, 1996, Volume: 9, Issue:5

    Topics: Animals; Brain Neoplasms; Glioma; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Neoplasm Trans

1996
Effect of 6-aminonicotinamide on metabolism of astrocytes and C6-glioma cells.
    Metabolic brain disease, 1997, Volume: 12, Issue:1

    Topics: 6-Aminonicotinamide; Adenosine Triphosphate; Animals; Animals, Newborn; Astrocytes; Brain Neoplasms;

1997
Alterations of lactate (+lipid) concentration in brain tumors with in vivo hydrogen magnetic resonance spectroscopy during radiotherapy.
    Investigative radiology, 1997, Volume: 32, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Brain Chemistry; Brain Neoplasms; Female; Glioblastoma; Humans; Lact

1997
Intralesionally implanted cisplatin cures primary brain tumor in rats.
    Journal of surgical oncology, 1997, Volume: 64, Issue:4

    Topics: Animals; Brain Neoplasms; Cisplatin; Delayed-Action Preparations; Drug Implants; Gliosarcoma; Lactic

1997
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
    Journal of neurosurgery, 1997, Volume: 87, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplas

1997
Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy.
    International journal of radiation oncology, biology, physics, 1998, Jan-15, Volume: 40, Issue:2

    Topics: Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Female; Humans; Lactic Acid; Magnet

1998
Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification.
    Journal of neuro-oncology, 1998, Volume: 36, Issue:2

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Gliosarcoma; Hydrogen-Ion Concentration; Indazoles;

1998
In vivo single-voxel proton MR spectroscopy in intracranial cystic masses.
    AJNR. American journal of neuroradiology, 1998, Volume: 19, Issue:3

    Topics: Adult; Amino Acids; Brain Abscess; Brain Diseases; Brain Neoplasms; Cysticercosis; Cysts; Female; Ga

1998
Treatment of brain tumors in children is associated with abnormal MR spectroscopic ratios in brain tissue remote from the tumor site.
    AJNR. American journal of neuroradiology, 1998, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Aspartic Acid; Brain; Brain Neoplasms; Child; Child, Presc

1998
In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors.
    Journal of magnetic resonance (San Diego, Calif. : 1997), 1998, Volume: 133, Issue:2

    Topics: Aspartic Acid; Brain Chemistry; Brain Neoplasms; Choline; Creatine; Female; Humans; Lactic Acid; Lip

1998
Modulation of VEGF production by pH and glucose in retinal Müller cells.
    Current eye research, 1998, Volume: 17, Issue:9

    Topics: Animals; Brain Neoplasms; Cell Hypoxia; Cells, Cultured; Endothelial Growth Factors; Enzyme-Linked I

1998
Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy.
    Cancer research, 1998, Nov-15, Volume: 58, Issue:22

    Topics: Animals; Brain Neoplasms; Carbon Isotopes; Glioma; Glucose; Glutamic Acid; Glycolysis; Lactic Acid;

1998
Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.
    AJNR. American journal of neuroradiology, 1999, Volume: 20, Issue:1

    Topics: Adult; Aged; Analysis of Variance; Aspartic Acid; Astrocytoma; Biopsy; Body Water; Brain Neoplasms;

1999
Comparison of MR spectroscopy and MR imaging with contrast agent in children with cerebral astrocytomas.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 1999, Volume: 15, Issue:8

    Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Gadolinium

1999
Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model.
    British journal of cancer, 2000, Volume: 82, Issue:1

    Topics: Animals; Brain Neoplasms; Coated Materials, Biocompatible; Drug Delivery Systems; Female; Glioma; Id

2000
Effect of voxel position on single-voxel MR spectroscopy findings.
    AJNR. American journal of neuroradiology, 2000, Volume: 21, Issue:2

    Topics: Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glio

2000
[Effect of normobaric hyperoxia on parameters of brain metabolism].
    Anaesthesiologie und Reanimation, 2000, Volume: 25, Issue:3

    Topics: Adult; Anesthesia, Intravenous; Blood Gas Analysis; Brain; Brain Neoplasms; Craniotomy; Energy Metab

2000
Extracellular glutamate and other metabolites in and around RG2 rat glioma: an intracerebral microdialysis study.
    Journal of neuro-oncology, 2000, Volume: 47, Issue:1

    Topics: Amino Acids; Animals; Ascorbic Acid; Brain Chemistry; Brain Neoplasms; Extracellular Space; Female;

2000
Quantitative proton magnetic resonance spectroscopy of focal brain lesions.
    Pediatric neurology, 2000, Volume: 23, Issue:1

    Topics: Adolescent; Aspartic Acid; Biomarkers, Tumor; Brain; Brain Abscess; Brain Diseases; Brain Neoplasms;

2000
In vivo study of tumor metabolism: an application of new multi-probe microdialysis system in the striatum of freely moving rats grafted with C6 cells.
    Brain research, 2000, Oct-27, Volume: 881, Issue:2

    Topics: Animals; Brain Neoplasms; Corpus Striatum; Glioma; Glucose; Lactic Acid; Male; Microdialysis; Pyruvi

2000
Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.
    AJNR. American journal of neuroradiology, 2001, Volume: 22, Issue:4

    Topics: Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Energy Metabolism; Female; Follow-Up Studies;

2001
Proton magnetic resonance chemical shift imaging (1H CSI)-directed stereotactic biopsy.
    Acta neurochirurgica, 2001, Volume: 143, Issue:1

    Topics: Adult; Aspartic Acid; Biopsy, Needle; Brain; Brain Neoplasms; Creatine; Diagnosis, Differential; Ene

2001
An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery.
    Journal of magnetic resonance imaging : JMRI, 2001, Volume: 14, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Astrocytoma; Biopsy; Brain; Brain Mapping; Brain Neop

2001
High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
    Cancer research, 2001, Jul-15, Volume: 61, Issue:14

    Topics: Alanine; Animals; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Ethanolamines; Female; Glioma;

2001
Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.
    European radiology, 2001, Volume: 11, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Chil

2001
Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.
    Cancer research, 2001, Sep-01, Volume: 61, Issue:17

    Topics: Animals; Aspartic Acid; Brain Neoplasms; Buffers; Choline; Contrast Media; Creatine; Extracellular S

2001
Effect of exogenous lactate on rat glioma metabolism.
    Journal of neuroscience research, 2001, Sep-15, Volume: 65, Issue:6

    Topics: Animals; Blood Glucose; Brain; Brain Neoplasms; Carbon; Carbon Radioisotopes; Citric Acid Cycle; Ene

2001
Improved analysis of 1H-MR spectra in the presence of mobile lipids.
    Magnetic resonance in medicine, 2001, Volume: 46, Issue:3

    Topics: Alanine; Artifacts; Brain; Brain Diseases; Brain Neoplasms; Glioblastoma; Glioma; Humans; Image Enha

2001
Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma.
    Neurosurgery, 2001, Volume: 49, Issue:4

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Dominance, Cerebr

2001
Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients.
    Journal of neurology, neurosurgery, and psychiatry, 2001, Volume: 71, Issue:5

    Topics: Adolescent; Adult; Aged; Albumins; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Infant;

2001
Diffusion-weighted in vivo localized proton MR spectroscopy of human cerebral ischemia and tumor.
    NMR in biomedicine, 2002, Volume: 15, Issue:1

    Topics: Adult; Aspartic Acid; Brain Ischemia; Brain Neoplasms; Cerebral Infarction; Creatine; Diffusion; Fem

2002
Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2002, Volume: 53, Issue:3

    Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Brain; Brain Neoplasms; Contrast Media; Dif

2002
Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.
    Radiology, 1992, Volume: 185, Issue:3

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Female; Glucose;

1992
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
    Annals of neurology, 1992, Volume: 31, Issue:3

    Topics: Acute Disease; Adult; Aspartic Acid; Biopsy; Brain Chemistry; Brain Neoplasms; Choline; Creatine; De

1992
In vivo imaging of glucose consumption and lactate concentration in human gliomas.
    Annals of neurology, 1992, Volume: 31, Issue:3

    Topics: Adult; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Glycolysis; H

1992
Spatially localized in vivo 1H magnetic resonance spectroscopy of an intracerebral rat glioma.
    Magnetic resonance in medicine, 1992, Volume: 23, Issue:1

    Topics: Animals; Aspartic Acid; Brain; Brain Neoplasms; Creatine; Female; Glioma; Hydrogen; Lactates; Lactic

1992
In vivo 1H-spectroscopy of human intracranial tumors at 1.5 tesla. Preliminary experience at a clinical installation.
    Acta radiologica (Stockholm, Sweden : 1987), 1991, Volume: 32, Issue:2

    Topics: Adult; Aged; Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Creatine; Female; Humans; Lactate

1991
A pitfall associated with lactate detection using stimulated-echo proton spectroscopy.
    Magnetic resonance in medicine, 1991, Volume: 17, Issue:2

    Topics: Alanine; Brain Chemistry; Brain Neoplasms; Fourier Analysis; Humans; Hydrogen; Lactates; Lactic Acid

1991
The role of transmembrane pH gradients in the lactic acid induced swelling of astrocytes.
    Brain research, 1990, Jul-16, Volume: 523, Issue:1

    Topics: Alanine; Astrocytes; Brain Neoplasms; Cell Membrane; Dimethadione; Glioma; Humans; Hydrogen-Ion Conc

1990
Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
    Radiology, 1989, Volume: 172, Issue:2

    Topics: Adult; Aspartic Acid; Brain Chemistry; Brain Diseases; Brain Neoplasms; Choline; Creatinine; Cysts;

1989
Lactate and pH in the brain: association and dissociation in different pathophysiological states.
    Journal of neurochemistry, 1987, Volume: 48, Issue:1

    Topics: Animals; Brain; Brain Ischemia; Brain Neoplasms; Hydrogen-Ion Concentration; Ischemic Attack, Transi

1987
Regional metabolism of experimental brain tumors.
    Acta neuropathologica, 1986, Volume: 69, Issue:1-2

    Topics: Adenosine Triphosphate; Animals; Brain Neoplasms; Cell Line; Glucose; Glycolysis; Hydrogen-Ion Conce

1986
Regional quantitative determination of lactate in brain sections. A bioluminescent approach.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1985, Volume: 5, Issue:4

    Topics: Animals; Brain; Brain Chemistry; Brain Ischemia; Brain Neoplasms; Freeze Drying; Gerbillinae; Glucos

1985